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ABSTRACT 
Human noroviruses (HNoVs) and Aichi virus (AiV) cause significant numbers of 
gastrointestinal diseases worldwide. Tulane virus (TV), a cultivable HNoV surrogate, 
is used to determine control measures against HNoV. The objectives of this study were 
to determine the heat inactivation kinetics of TV and AiV in cell-culture media and TV 
in spinach using the first-order and Weibull models. TV and AiV in cell-culture media 
at ~7 log PFU/ml in 2-ml glass vials were heated at 50-58°C [degree Celsius] up to 10 
min in a circulating water-bath. Surviving infectious viruses were enumerated by 
standard plaque assays using confluent host cells in 6-well plates. First-order model 
D-values for TV at 52, 54, 56 and 60°C were 4.59±0.02, 2.91±0.01, 1.74±0.41 and 
0.58±0.36 min, respectively, with a z-value of 9.09±0.01°C. The Weibull model showed 
Td=1 [thermal decimal reduction time] values of 2.53±0.08, 1.99±0.10, 0.57±0.64 and 
0.22±0.25 min, respectively at the same temperatures with a z-value of 6.99°C for cell 
culture media in 2-ml glass vials. D-values for TV in spinach in vacuum bags were 
7.94±0.09, 4.09±0.04 and 1.43±0.07min and a z-value of 10.74±0.01°C by the first-
order model and 4.89±0.02, 3.21±0.45 and 0.25±0.38 min for the Weibull model at 50, 
54 and 58°C, respectively. TV may not be as suitable a surrogate as MNV-1 for HNoV 
heat inactivation studies in cell culture media in 2-ml glass vials or spinach in vacuum 
bags owing to its lower D and z-values (with D50°C of 36.28 min in cell-culture media 
and 14.57 min in spinach in 2-ml vials). D-values for AiV in 2-ml glass vials at 50, 54, 
and 58°C from the first-order model were 47.62±1.2, 7.14±1.13 and 2.12±0.04 min, 
respectively, with a z-value of 5.92°C, while the Weibull model showed Td=1 values of 
34.53±0.03, 2.59±0.05 and 0.91±0.06 min for the same temperatures, respectively. 
Thus, both TV and AiV have lower heat resistance than hepatitis A virus (D56°Cof 8.4 
min in buffer in 2-ml glass vials and 8.43 min in spinach in vacuum bags). This study 
helped in understanding the heat-inactivation kinetics of AiV and TV that provide data 
for use in thermal processing to ensure food safety. 
Keywords: Tulane virus, Aichi virus, Human norovirus, heat inactivation, D-value, z-
value 
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INTRODUCTION 
Human noroviruses (HNoVs) and Aichi virus (AiV), known causative agents of 
gastroenteritis, have been increasingly associated with foodborne illnesses outbreaks 
worldwide. Currently, there are no known available vaccines or prescribed antiviral 
agents for HNoV or AiV infections. Therefore, effective inactivation strategies need to 
be researched to prevent the spread these viruses. Due to the difficulty in assessing 
infectivity and the current unavailability of animal models or reproducible cell culture 
infectivity assays for HNoVs, animal cultivable surrogates such as murine norovirus 
(MNV-1), feline calicivirus (FCV-F9), porcine enteric sapovirus (PEC), and Tulane 
virus (TV) are used (19, 33, 49, 59, 68). 
Thermal processes have been traditionally and most-widely used to inactivate 
pathogens in food, thus preserving food and extending the shelf-life. Heat is known to 
disrupt hydrogen bonding and destroy the structural integrity of proteins, thereby 
leading to protein denaturation of viral capsid proteins into non-infectious viral subunits 
and single individual proteins (22, 107). Above 60°C, after the potential destruction of 
host-cell recognition and binding receptors occur, an alteration of the tertiary protein 
structure occurs, which facilitates the access of thermal energy to the nucleic acid 
material (10). For industrial purposes and to understand heat inactivation kinetics of 
microorganisms, D- and z-values are determined. The D-value is defined as the time 
at a given temperature necessary to reduce a microbial population present in a defined 
medium by 90% and is indicative of the thermal resistance of a microorganism at a 
constant temperature (13). The z-value is the change in temperature required to 
increase or decrease the D-value by 90% and is indicative of the temperature 
dependence of microbial inactivation (13, 19). Inversion of the slope of log D versus 
temperature thus provides the z-value. Earlier research reports are available on 
cultivable human norovirus surrogates, feline calicivirus (FCV-F9), murine norovirus 
(MNV-1) as well as hepatitis A virus (HAV) in buffer and in food matrices such as 
spinach, deli meats and shellfish (17, 21, 22, 129). 
 
TV has similarities to HNoV such as being similar in size, shape and structure 
(30-35 nm, icosahedral shape, with a positive-sense single-stranded RNA), 
recognition of histo blood antigen receptors A and B, and disease symptoms (46). 
Previous studies have shown high resistance of TV as compared to other HNoV 
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surrogates (MNV-1 or FCV-F9) to different environmental conditions such as pH, high 
hydrostatic pressure, aq. chlorine (33), making it a suitable surrogate for studying 
HNoV inactivation approaches. 
Owing to the variety of food products associated with foodborne virus 
contamination, their fecal-oral route of transmission and low infectious dose, there is 
a vital need for the development of cost-effective inactivation techniques. 
 
The objectives of this study were to: 
Objective 1: Determine the heat inactivation kinetics of TV as HNoV surrogate in cell 
culture media in 2-ml glass vials and in spinach within vacuum bags, with comparison 
of Linear and Weibull models. 
 
Objective 2: Determine the heat inactivation kinetics of AiV in cell culture media in 2-
ml glass vials with comparison of Linear and Weibull models. 
 
Based on these results, the heat-inactivation kinetics would be determined that could 
be potentially used in industrial settings for appropriate processing of foods to prevent 
outbreaks. 
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CHAPTER I  
LITERATURE REVIEW 
  
4 
 
1 FOODBORNE VIRUSES 
1.1 Human Noroviruses 
Human noroviruses (HNoV) are the leading causative agents of acute 
gastroenteritis worldwide and are responsible for illness of 1 in every 15 people, with 
about 56,000-71,000 hospitalizations and 570-800 deaths each year (56). Fever, 
diarrhea, vomiting, chills and severe dehydration are some of the common symptoms 
of HNoV infection which develop within 12-48 hours after infection and can last for 24-
72 hours (95, 109, 126). As analyzed by the Centers for Disease Control and 
Prevention (CDC), there were 1,008 HNoV outbreaks in the 43 states of USA from 
2009-2012, out of which 92% resulted from the consumption of contaminated 
vegetables, fruits and mollusks (56), minimally processed food and fresh produce, 
shellfish, ready-to-eat meals, sandwiches, baked products, water and ice (96, 132). 
These viruses pose a potential risk to public health as even a small amount of 
contamination can cause/result in disease outbreaks and spread through water, food, 
person to person contact and aerosolized vomitus (59). This varied means of 
transmission along with their environmental stability, low infectious dose, association 
with a wide range of produce and food commodities and resistance to disinfectants 
and mild processing conditions contribute towards the challenge of controlling HNoVs. 
Human noroviruses belong to the Caliciviridae family and are non-enveloped, 
30-35 nm virions with an icosahedral symmetry that contain a single-stranded positive-
sense RNA of 7.5 to 8.5 kb in length enclosed in a capsid (15, 46). Out of the five 
genera of Caliciviridae family which are Norovirus, Sapovirus, Vesivirus, Norovirus and 
Lagovirus, HNoV belongs to the genus Norovirus (15). Their RNA genome is known 
to have three open reading frames (ORFs) with ORF1 encoding nonstructural proteins 
including the RNA dependent RNA polymerase (RdRp); ORF2 encoding major viral 
proteins that form the capsid (VP1) and has protruding (P) domain and shell (S) 
domain; and ORF3 encoding minor viral protein (VP2) (39). The ORF1 encodes a 
polyprotein that is post-translationally cleaved into seven non-structural mature 
proteins (NS1 to NS7) that are involved in viral replication (126). 
The P domain was shown to have  better binding ability than VP1  to the viral 
histo-blood group antigens receptors (84). Human histo-blood group antigens 
(HBGAs) are complex carbohydrates linked to glycoproteins or glycolipids that are 
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present on red blood cells and mucosal epithelial cells or as free antigens in biological 
fluids, such as blood or saliva (117). Six different HBGA binding patterns shown by 
HNoVs are - recognition of HBGAs of type A and O secretors; recognition of A, B, and 
O secretors; A and B secretors; A secretors and two Lewis-epitope binders (117).  
Based on the capsid sequences, currently there are seven known genogroups 
of HNoV out of which GI, GII and GIV affect humans, GIII and GV affect bovines and 
GVI and GVII affect canines (46, 126). Based on the complete VP1 and the RNA 
dependent RNA polymerase (RdRp) amino acid sequence, currently there are 9 
genotypes of GI, 22 of GII, 2 of each GIII, GIV, GV and GVI, and 1 in the tentative new 
GVII (126). Among the GII strains, GII.4 has been the most prevalent for example, 
HNoV GII.4 Minerva, along with the new emerging GII.17 strain (29, 38). 
The many recent outbreaks related to HNoV worldwide are summarized in 
Table 1. In mid-March 2015, two patients in a geriatrics ward suffered from diarrhea in 
a healthcare facility in Belgium, and though the outbreak was controlled in 22 days, 27 
patients had experienced diarrhea, 12 of whom tested positive for HNoV genogroup II 
(100). From 2004–2008, in the US approximately 66% of all HNoV nosocomial 
infections occurred in elderly adults, with mortality rates roughly 200% higher among 
those ≥65 years compared to <5 year olds (78). In older adults, HNoVs cause 
approximately 10–20% of gastrointestinal hospitalizations, 10–15% of gastroenteritis 
deaths (78). Among older adults HNoV GII.4 was the most predominant genotype 
related to inpatient, long term care facility and community settings, potentially due to 
a combination of novel GII.4 mutations (78). 
When 16 healthy secretor positive adults orally received different dosages of 
HNoV inoculum (10-fold dilutions ranging from 4.8 to 4,800 RT-PCR units), 
gastroenteritis developed in 11 persons (8). The researchers observed that virus 
shedding (measured by immunomagnetic capture RT-PCR) was first detected at a 
median of 36 hours after inoculation and lasted a median of 28 days after inoculation 
(8). Seronegative chimpanzees inoculated with HNoV GI.1, were not shown to have 
any sign of gastroenteritis, but there were similarities in the onset and duration of virus 
shedding in stool and serum antibody responses to that observed in humans (15). 
When two infected chimpanzees were rechallenged 4, 10, or 24 months later with NV, 
the chimpanzees were reported to be resistant to reinfection, possibly due to the 
presence of HNoV-specific serum antibodies (13). Moreover, intramuscular 
vaccination of these chimpanzees with GI virus like particles (VLPs) caused protection 
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from HNoV infection when challenged 2 and 18 months later, whereas GII virus like 
particles (VLPs) vaccine or a placebo did not cause protection (15). Hence, further 
research on vaccination schemes are needed. 
With regards to HNoV propagation in the lab, some researchers have shown 
that HNoV infection is possible with cells in 3D systems. One-day human intestinal 
epithelium cells in 3 dimensions (3-D) on 24-well plates containing collagen-I–coated 
porous microcarrier beads in rotating-wall vessel (RWV) bioreactors were infected four 
times until passage 5 with HNoV GI and GII, that were extracted from stool samples 
obtained from cruise-ship and nursing home outbreaks (109), and showed cytopathic 
effects (CPE) after 24-48 h post infection. Successful norovirus replication was 
observed through all 5 passages in the 3-D small intestinal model, which was 
confirmed by CPE, RT-PCR, and fluorescence in situ hybridization (FISH) with 
genogroup-specific molecular beacons (109). 
On the other hand, some researchers show that 3D cell aggregates do not allow 
infection or replication of HNoV (88), without any infection or CPE withGII.4 on 
differentiated 3D cell culture systems of human embryonic intestinal epithelial cells 
(Int-407) and human epithelial colorectal adenocarcinoma cells (Caco-2) grown on 
collagen-I porous micro carrier beads in a rotating bioreactor as analysed by RT-PCR 
(88). After 48 h of infection, no increase in the viral RNA titer compared with 1h post 
inoculation was observed(88).GII.4-Sydney HNoV-positive stool sample with 6 log 
genome copy numbers inoculated onto the BJAB human B cell line, showed a 
significant 10-fold and 25-fold increase in viral genome copy number at 3 and 5 dpi, 
respectively, compared with input levels(63).Filtration of the HNoV-positive stool 
sample over a 0.2µm membrane, caused decrease in genome replication indicating 
the presence of a filterable cofactor. The researchers showed that HNoV genomes 
increased fourfold and 20-fold at 3 and 5 dpi, respectively, after inoculation with 
passage 0 (P0) virus, which indicates that primary BJAB infection results in the 
production of new infectious virus particles (63). 
HNoV GII.4-Sydney-positive stool when applied into the apical supernatant fluid 
of polarized human colon adenocarcinoma cell line HT-29 intestinal epithelial cells 
(IECs), caused a 600-fold increase in viral genome copy number in the B cell fraction 
of infected cultures at 3 dpi (63), without any increase in the number of viral genome 
copy in the absence of B cells. Moreover, filtration of the stool sample ablated B cell–
associated viral genome replication, which was consistent with the results observed 
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for direct B cell infections (63).These researchers observed that there was no increase 
in infectivity of HNoV with either Escherichia coli (which did not express H antigen) or 
lipopolysaccharide (LPS, a component of the outer membrane of Gram-negative 
bacteria), whereas synthetic H antigen restored infectivity of filtered stool comparably 
with E. cloacae (63). 
 When monolayers of human intestinal enteroids (HIE) were inoculated with 
HNoV GII.4, 1.5-2.5 log increase in genome equivalents (using RT-qPCR) at 96 hours 
post-infection was reported (45). HNoV GII.3 and GII.4 viral replication (measured by 
RT-qPCR and immunofluorescent assays) was promoted when the researchers used 
human, sow and commercially available bovine and porcine bile which was due to bile 
effect on HIEs (45). This marks the beginning of the cultivation and propagation of 
HNoVs in the laboratory, though still expensive and is still at the infancy stage at the 
time of this writing. Few studies on inactivation of HNoV are reported where HNoV 
GII.4 was reduced by only 1.69 log genomic equivalents/ml on exposure to cold 
atmospheric plasma (at 30 mW/cm2, 23.5°C and 40% relative humidity for 15 min (3). 
About 3 and 2.8 log receptor captured viral genomic signal (RCVGS) reduction on 
exposure to UV at 1 J/cm2 and 100°C for 2min, respectively was reported for HNoV 
GII.4 (127). A 2.9 log reduction in RNA level of HNoV GII.4  has been reported on 
exposure to high hydrostatic pressure processing (HHP) at 250 MPa at 1°C (76). 
 Since, there were no reproducible cell-culture based systems or infectivity 
assays for HNoV propagation and detection at the time of this study, cultivable 
surrogates were used to determine inactivation, transmission and persistence in the 
environment. An ideal surrogate for HNoV should be similar in structure and size, have 
greater resistance, should be non-pathogenic and easy to use in lab. Currently, Feline 
Calicivirus (FCV-F9), Murine Norovirus (MNV-1), Tulane Virus (TV), Porcine 
Sapovirus (SaV), bacteriophages and virus like particles (VLPs) are therefore used as 
cultivable HNoV surrogates (33, 35, 130). 
 
1.2 HNoV surrogates 
1.2.1 Murine Norovirus 
 Murine Norovirus (MNV-1) belongs to genogroup V of the genus Norovirus in 
the family Caliciviridae. MNV-1 is 28 to 35 nm in diameter, icosahedral in shape, non-
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enveloped, and has a buoyant density of 1.36 g/cm3 which is characteristic of HNoVs. 
It has a positive-sense single-stranded 7.5 kb RNA genome. It is replicable in the 
laboratory using murine macrophage RAW 264.7 cells (131). It is known to infect mice 
deficient in components of innate immunity and cause diarrhea and lethality (120). 
ORF1 of MNV-1 encodes a predicted 187.5kDa polyprotein containing the 2C 
helicase, 3C protease, and 3D polymerase motifs found in other caliciviruses and 
picornaviruses. ORF2 of MNV-1 encodes a 58.9 kDa capsid protein that can self-
assemble into virus-like particles while ORF3 of MNV-1 encodes a 22.1 kDa basic 
protein (120, 131). 
MNV-1 has been reported to show a 3.4 and 0.9 log PFU/ml reduction on high 
hydrostatic pressure (HHP) treatment at 400 MPa at 21°C for 2min in cell culture 
media at neutral pH (76). Thermal inactivation at 56°C of MNV-1 in cell culture media 
showed a D-value of 3.65 and 3.74 min in glass capillary tubes and 2 ml glass vials, 
respectively (18, 22, 33), while it was reported to show a 5 log TCID50/ml reduction in 
polypropylene microcentrifuge tubes at 56°C (33). It was highly sensitive to UV 
showing complete reduction at 10 mW/cm2 for 2min, 4.1 log PFU/ml reduction in viral 
titer on using either 6% wt/wt ozone for 10 min or pulsed light on polyethylene disks at 
8.98 J/cm2 (79, 95, 125). It is highly pH resistant as it has been reported to show 0.2 
and 2 log PFU/ml reduction in infectivity using 100mM citric acid (pH 2) and 100mM 
carbonate buffer (pH 10) for 30 min at 37°C while there was 1.4 log PFU/ml reduction 
with commercial bleach at 1,000 ppm chlorine for 5 min at room temperature on 
stainless steel discs (33). 
1.2.2 Feline Calicivirus 
Feline Calicivirus is a non-enveloped icosahedral virus which belongs to the 
genus Vesivirus is known to cause respiratory diseases in both domestic and exotic 
cats with morbidity up to 30%. It is 27-40 nm in size with a positive sense single 
stranded 7.7 kb RNA. It is cultivable in lab using the host Crandell-Reese feline kidney 
cell line (28). 
Reports indicate a 4 log PFU/ml reduction in FCV-F9 viral titer on exposure to 
29 mJ/cm2 UV in cell culture media (90) and a 4 log TCID50/ml reduction upon 
exposure to Ar atmospheric plasma for 180s at 1.5W (1). Thermal inactivation studies 
of FCV-F9 in cell culture media shows D-values at 56°C as 6.3 min using both capillary 
tubes and 2-ml glass vials (18, 22) and reduction to non-detectable levels in 
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microcentrifuge tubes after 20min at 56°C (33). It has shown to be reduced to non-
detectable levels upon treatment with 100mM citric acid (pH 2) and 100mM carbonate 
buffer (pH 10) for 30 min at 37°C and 5.3 log PFU/ml reduction using commercial 
bleach at 1,000 ppm chlorine for 5 min at room temperature on stainless steel discs 
(33).Due to its respiratory transmission route, vulnerability and low sensitivity to pH, 
environmental stress, elevated temperatures and chemical disinfectants, it may not 
accurately predict HNoV stability or inactivation and may not be the most suitable 
HNoV surrogate (18, 27, 44). 
1.2.3 TV 
 Tulane virus was recently isolated from stool samples of rhesus monkeys and 
belongs to the genus Recovirus in the Caliciviridae family(129). It is small, non-
enveloped, and icosahedral with positive sense, single stranded RNA genome which 
is 6714 nt in length and 40 nM in diameter (46). Both, HNoV and TV have three open 
reading frames (ORF) wherein ORF1 encodes non-structural protein, ORF 2 encodes 
capsid protein (VP1) and ORF 3 encodes minor structural proteins (VP2) (46). The 90 
dimers of capsid protein are divided into two domains, the Shell domain (S) which is 
an eight folded jellyroll structure and forms the icosahedral shell and the protruding 
domain (P) with subdomains P1 and P2, that are responsible for the viral entry into the 
host cell (139). The VP1 (capsid protein) is 534 amino acid (aa) with a molecular mass 
of 57.9 kilo Daltons, whereas VP2 (minor structural protein) is 218aa and has a 
molecular mass of 22.8 kDa. It is cultivated in the lab using LLC-monkey kidney 
cells(46).Similar to HNoV, it binds to histo-blood group antigens and is closely related 
to HNoV GII (59). Hence, this cultivable virus is used to determine appropriate 
inactivation methods against HNoV. 
 TV shows reduction in infectivity of 1.2 log PFU/ml when treated with 
commercial bleach at 1,000 ppm chlorine for 5 min at room temperature on stainless 
steel discs (33). TV is also known to be highly resistant to high pressure processing 
showing 6 log PFU/ml reduction at 600 MPa for 1 min at 4°C and shows 0.2 and 2 log 
PFU/ml reduction in infectivity using 100mM citric acid (pH 2) and 100mM carbonate 
buffer (pH 10) for 30 min at 37°C (33). These previous findings suggest that in 
comparison to other HNoV surrogates, TV is most resistant to change in pH, pressure 
or chlorine concentration under the above given conditions, and is therefore a suitable 
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surrogate for HNoV for the above mentioned processing and inactivation approaches.
  
1.2.4 Porcine Sapovirus 
The prototype strain of human Sapovirus SaV, the Sapporo virus, was identified 
originally in faecal specimens by electron microscopy (EM) from an outbreak in an 
orphanage in Sapporo, Japan, in 1977 (128). SaVs are known to cause enteric 
diseases in humans of all ages but more so in younger children. Based on complete 
capsid sequence, out of the five genogroups, GI, GII, GIV, and GV are found to infect 
humans and GIII infects pigs. The genomes of the SaVs are organized into two ORFs 
(71). A number of Sapovirus strains are also predicted to contain an additional small 
ORF overlapping with the 5’ end of the capsid gene (70). It can be cultivated in the lab 
using LLC-porcine kidney cells. It has been reported to show 2.2, 1.2 and 2.38 log 
TCID50/ml reduction with 70% ethanol for 30s,10 mg/l sodium hypochlorite for 1 min 
and heat treatment at 56°C for 30 min, respectively (130). 
1.2.5 Bacteriophage MS2 
Bacteriophage MS2 is an icosahedral single stranded RNA virus (26nm) that 
belongs to RNA coliphages group I in the Leviviridae family. It has Escherichia coli as 
its natural host and is therefore commonly found in sewage waste and animal faeces 
(35). Like HNoVs, it is adapted to intestinal tract and has therefore been used as a 
surrogate to study behaviour of HNoV under different environments (35). Furthermore, 
it has been reported to survive for up to 50 days at 4 and 8°C, with a reduction of less 
than 1 log PFU/mL, and for up to 9 days (>1 log PFU/mL reduction) at 22°C on fresh 
produce such as leafy greens, carrot, tomato, strawberries, and raspberries (35). 
1.2.6 Virus like particles (VLPs) 
They are non-infectious HNoV particles which can be expressed in baculovirus-
infected insect cells, and can bind to HBGA receptors on mucosal cell surfaces and 
are known to be acid and heat stable (62). They can be assembled by expression of 
the capsid protein in insect cells such as Spodopterafrugiperda Sf21 cells (12).  
1.3 AiV 
The emerging foodborne enteric Aichi virus (AiV) was first isolated from stool 
specimens of patients suffering with acute gastroenteritis due to the consumption of 
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contaminated raw oysters (135). This virus has a morphologically distinct round-
structure, ~ 20 to 40 nm in diameter that belongs to the Kobuvirus genus in the same 
Picornaviridae family as Hepatitis A virus (HAV). It has three known species A, B and 
C and is cultivable in lab using African green monkey kidney Vero cell line and 
infectivity can be determined through plaque assays (133, 135). The viral genome 
consists of a single-stranded, positive-sense RNA molecule of 8,280 nucleotides and 
a poly (A) tail (5, 133). AiV is transmitted through the faecal oral route and has been 
known to spread through contaminated water and shellfish (72, 97, 133, 134). It has 
been thus far isolated from stool  samples over the world including Japan, France, 
Pakistan, Netherlands, Tunisia, Spain and South America (72, 85, 98, 133, 134). 
Symptoms of AiV infection include nausea, vomiting and diarrhea within 12 to 48 h 
after ingestion, while faecal shedding of AiV can last up to 5-7 days after infection and 
the infectious dose is currently not known (30, 116). Currently there are no antivirals 
described for AiV infection treatment (14).It has been shown to be highly resistant than 
other HNoV surrogates under different environmental conditions of inactivation 
including heat, pH, high pressure processing, chlorine bleach and alcohol (33). 
The unavailability of antiviral treatments and low infectious dose of HNoVs 
(119) and a number of methods of transmission necessitates the prevention of spread 
and contamination of HNoV through sanitation and hygienic practices or by using 
inactivation techniques. 
 
2 INACTIVATION TECHNIQUES 
There have been various studies on novel techniques for inactivation of HNoV and its 
surrogates.  
2.1 Chemical 
2.1.1 Ethanol 
Ethanol alters the structural integrity of viral capsid proteins and increases the 
permeability while in the case of enveloped viruses, it dissolves the envelope lipids 
(82). Ethanol at 70% for 1min was reported to result in a 3.54 average log reduction in 
genomic copies/ml (gc/ml) of HnoV GII.4 (2).Treatment of HNoV GII.4 in 1.5 ml micro-
12 
 
centrifuge to an ethanol concentration of 70% for 20s at room temperature reduced 
the log of RCVGS from 2.5 (untreated) to 0.05 (treated) (127). 
FCV-F9 when treated with 75% ethanol for 1min in pollyalomer ultracentrifuge 
tubes showed 1.25 log TCID50/ml reduction (40). MNV-1 has been reported to show 5 
log PFU/ml reduction in viral titer using 70 and 90% ethanol or isopropanol for 1 min, 
while TV and AiV had <1 log PFU/ml reduction under the same conditions (33). 
Whereas, FCV-F9 showed ~1.5 log PFU/ml reduction with 70% ethanol for 1 min (33). 
2.1.2 Trisodium phosphate (TSP) 
TSP is a common cleaner which has an alkaline pH of 12. It has been approved 
for beef carcass decontamination by Food Safety Inspection Services. It is known to 
inactivate virus by destabilizing the viral capsid (9). HNoV GI.1 (initial titer of 8 log 
genomic equivalents/ml) on exposure to TSP at 5% for 5min showed 1.6 log reduction 
in binding (68).Kim et al, 2015 mixed MNV-1 with ethanol to a final concentration of 
30%, 5% and 70% treated with TSP at 1%, 2% and 5% up to 30min at 25°C on SS 
discs at 4°C for 0, 1, 5, 15, and 30 min (using RT-PCR), as well as tested on lettuce 
and bell peppers (65). The researchers found that in the case of ethanol, there were 
persisting RT-PCR products of MNV-1 after using 70% ethanol. Whereas, MNV-1 was 
inactivated after 1min by using 2% and 5% TSP, as was also shown earlier (34) that 
there was 7 log reduction after 15 s using 5% TSP on MNV-1 (34). They also showed 
that in case of combined effect, MNV-1 was completely reduced after 5 mins in solution 
whereas, for lettuce and bell pepper matrices, there was complete inactivity after 15 
and 1min on exposure to 1% TSP and 30% ethanol (65). 
FCV-F9 and MNV-1 (at 7 log PFU/ml) spiked on lettuce and jalapeno peppers 
have been studied for treatment with 2 and 5% TSP and 200mg/L sodium hypochlorite 
for 15 and 30 s at room temperature (111). FCV-F9 was reduced by 5 and 1.4 log 
PFU/mL with 2% TSP and 200 mg/L sodium hypochlorite, respectively while MNV-1 
was decreased by ∼2-3.4 and 1.3 log PFU/mL with 2% TSP; and sodium hypochlorite, 
respectively, while both viruses, FCV-F9 and MNV-1 were reduced to undetectable 
levels using 5% TSP(111).MS2 was reported to be reduced by >6 and 4.5 log PFU/ml 
by 5 and 1% TSP, respectively in 30s (34). 
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2.1.3 Organic Acids 
The proposed mode of action of an organic acid is through damage of the viral 
capsid and by protein denaturation through low pH (99).Tannic acid at 0.2 mg/mL was 
shown to reduce FCV-F9 by 1.95 log PFU/ml and gallic acid at 0.1, 0.2, and 0.4 mg/mL 
was shown to reduce FCV-F9 by 2.50, 2.36, and 0.86 log PFU/mL, respectively in cell 
culture media after 2 h at room temperature (34).TV and MNV-1 (both at 7 log PFU/ml 
titer initially) in cell culture media showed only 0.2 log PFU/ml reduction in infectivity 
using 100mM citric acid (pH 2) after 30 min at 37°C, while FCV (at 9 log PFU/ml 
initially) was reduced to undetectable levels initial (33).  
Levulinic Acid (LV), an acid anionic sanitizer that has been approved by FDA 
as a food additive (21 CFR 172.515),  at 0.5% with 0.1% sodium dodecyl sulfate (SDS) 
for 1min was effective in decreasing HNoV GI.1 and GII.4 by 8.97 and 8.13 average 
relative differences with and without RNAse A in RT-qPCR quantification cycle (Cq) 
values, respectively (initial titer of 3-5 log gc/ml) (2). When stainless steel (SS) 
coupons were inoculated with 6-8 log PFU/ml of MNV-1 and dried for 50min by using 
a carrier method at room temperature (16), average reductions of 0.85, 2.71 and 1.16 
log PFU/ml with sodium dodecyl sulfate (SDS), levulinic acid (LEV) with SDS and free 
chlorine, respectively were obtained after application with a conventional hydraulic 
spray apparatus(16). Use of electrostatic sprays of these sanitizers caused MNV-1 
reduction of 0.31, 1.16 and 1.66 log PFU/ml with SDS, LEV with SDS and free chlorine, 
respectively. When a robotic wiping device was used, reductions of 3.53, 7.05 and 
7.05 log PFU/ml for MNV-1 with SDS, LEV with SDS and free chlorine, respectively 
were reported(16).No reduction of HNoV GI.1 was reported with 0.5 % levulinic Acid 
(LV)/0.01 % Sodium Dodecyl Sulfate Treatments (SDS) (low), or 0.5 % LV/0.1 % SDS 
(high) for 1min (2).When FCV-F9 and MNV-1 at an initial titer of 6 log PFU/ml (partially 
purified cell lysates) were treated with 3% levulinic acid or 2% SDS, no reduction of 
MNV-1 or FCV-F9, with only 0.43 log PFU/ml reduction of FCV titer using 3% levulinic 
acid was obtained. However, both MNV-1 and FCV-F9 were reduced below detection 
limits of 2.7 log PFU/ml using 0.5% LVA with 0.5% SDS and 2% LVA with 1% SDS 
(26). 
2.1.4 pH 
The changes in the hydrogen ion concentration that leads to changes in the pH 
have been proposed to cause alteration in the viral capsid and hence denaturation of 
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nucleic material (99). Both TV and MNV-1 in cell culture media show 0.2 and 2 log 
PFU/ml reduction in infectivity using 100mM citric acid (pH 2) and 100mM carbonate 
buffer (pH 10) for 30 min at 37°C, whereas FCV-F9 is completely inactivated to non-
detectable levels at both pH 2 and pH 10 under the same conditions, while AiV showed 
<0.5log PFU/ml reduction (33). SaV has shown <1 log TCID50 reduction at pH 3 and 
8 using 0.2 M dibasic sodium phosphate or 0.1M citric acid (130). Therefore, TV and 
AiV showed highest resistance at pH 2 and 10, followed by MNV, while FCV-F9 
showed least resistance at both pH. 
 
2.1.5 Chlorine 
It is one of the common sanitizers and is approved by FDA for use as an antimicrobial 
agent in wash water for fruits and vegetables up to 3 ppm limit of residual aq. chlorine 
dioxide (US FDA 21 CFR Part 173.30). Mode of action is through alteration in the 
polypeptide backbone of viral capsid proteins (68). Hypochlorous acid (HOCl) is known 
to have antimicrobial activity against spore-forming bacteria (31). It is used for water 
purification, electrolysed water and chemical wash at 200ppm levels as a disinfectant 
for raw produce such as tomato, dairy and food processing equipment cleaning 
(USDA-Agricultural Marketing Services, 2011). There are two ways in which a sanitizer 
such as the chlorine based sanitizers HOCl and free chlorine could inactivate a non-
enveloped virus, by damaging the capsid sufficiently to prevent binding to host cell 
receptors, or secondly, damaging the RNA template within the target sequences 
preventing replication (108). 
Aqueous chlorine treatment with free chlorine levels showed reduction in the 
log receptor-captured viral genomic signal (RCVGS) of HNoV GII.4 (measured by in-
situ capture qRT-PCR) from 3.20 to 2.92, 2.68 and 2.34 at 2, 4 and 8 ppm of free 
chlorine, respectively after 10 min (127). HNoV GI.1 at an initial titer of 8 log genomic 
equivalents/ml (ge/ml) after treatment with 8.5% sodium hypochlorite at 33, 173 and 
189 ppm aqueous chlorine for 1 min at room temperature using PGM-MB binding 
assay showed 1.48, 3.65 and 4.14 log reduction in binding activity (68). Aqueous 
chlorine dioxide at 240 ppm for 10, 30 and 60min was also reported to result in 0.8, 
1.5 and 2.8 log reduction in binding of HNoV GI.1, respectively (68). Free chlorine has 
also been used to decontaminate fecally contaminated surfaces to control HNoVs (91). 
Using RT-PCR, HNoV GII.4 was shown to be reduced by 0.1 log in viral RNA after 
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120min using 0.1 mg/ml free chlorine at room temperature, whereas 0.5mg/ml chlorine 
further reduced HNoV GII.4 RNA by 3.21 log after 30min (69). Using RT-PCR, HNoV 
GII.4 was shown to be reduced by 0.6 log RNA copy number/ml after 10 min exposure 
to 500ppm NaOCl, whereas 5000 ppm NaOCl for 4 min showed a reduction of 1.4 log 
RNA copy number/ml (91). 
 On treating MNV-1 with free chlorine (prepared using sodium hypochlorite) at 
concentration 0-20 ppm for 3min, average infectious titer were reduced to by approx. 
2 and 3.5 log PFU/ml at 0.2 and 5 ppm, respectively and the log genomic copies/ml 
decreased by 0.2 and 0.4 units at 0.2 and 5 ppm, respectively (103). When MNV-1 
was spiked on lettuce (final concentration of 3 × 106 TCID50/ml) a peroxyacetic acid-
based biocide and chlorine prepared from sodium hypochlorite solution at 100 and 15 
ppm, respectively caused reduction by 1.4 and 2.3 log TCID50/ml (51). The 
researchers showed that peroxyacetic based biocide was more efficient for reducing 
the level of infectious MNV-1 on lettuce than bleach, with a reduction of 1.4 log and 
0.4 log TCID50/ml, respectively (51). MNV-1 reductions on spiked on plates, forks and 
drinking glasses after simple washing treatment were 2.6, 1.3 and 0.7 log PFU/ml, 
respectively (45), with mean reductions after washing and chlorine sanitation  of 3.2, 
1.5 and 1.4 log PFU/ml, respectively whereas after washing and sanitizing with the 
QAC sanitizer, caused reductions on the ceramic plates by 2.7 log PFU/ml and the 
mean reduction for both the forks and glasses were 1.6 and 1.4 log PFU/ml, 
respectively (47). 
For a 1 log TCID50/coupon reduction of MNV-1, 3.96 to 2.21 min were needed 
for treatment with 1,000 and 5,000 ppm of aqueous chlorine respectively whereas for 
3 logTCID50/coupon reduction required 4.98 to 2.25 min at 1,000 and 5,000 ppm 
respectively and for 5 logTCID50/coupon reduction the treatment time was 5.26 to 3.3 
min at 1,000 and 5,000 ppm, respectively (66). For FCV-F9, the treatment time was 
reduced from 2.77 to 1.33 min at 1,000 ppm aqueous chlorine for 1 log TCID50/coupon 
reduction and from 5.15 to 3.15 min at 5,000 ppm aqueous chlorine for 5 log 
TCID50/coupon reduction (66). 
The D-values at 1, 1.5, and 2 mg/liter chlorine dioxide gas for MNV-1 on 
inoculated stainless steel surfaces were 2.79, 2.07 and 1.87 min, respectively (138). 
The researchers stated that ClO2 gas after 1 at 2.5 mg/l reduced MNV-1 by ~3 log 
PFU/coupon and after 2min there was reduction to non-detectable levels. 
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Furthermore, 2, 2.5, and 4 mg/liter ClO2 reduced MNV-1 by 3 log PFU/coupon after 5, 
2, and 1 min, respectively (138). 
 HNoV GII.4 after treatment with hypochlorous acid solution (HAS) having free 
chlorine concentrations of 188, 38 and 18.8 ppm at a pH of 5.5 to 6.2 which was 
prepared electrolytically from dilute NaCl in Sterilox system, for different time points 
on ceramic and stainless steel tiles and in suspension showed 3 log reduction of viral 
RNA at room temperature after 20 min (89). MNV-1 was reduced by only 1 log PFU/ml 
at 2ppm aq. chlorine dioxide after 5min, whereas there was a 3 log PFU/ml reduction 
at 20 ppm after 5min using aq. chlorine dioxide (54). In the case of peroxyacetic acid 
based disinfectants, a 3, 4 and 4 log PFU/ml reduction of MNV-1 titer after 5 min at 
20, 85 and 250 ppm, respectively was reported (54). Further analysis of three 
disinfectants individually and in combination with Feclone on ready to eat foods such 
as blueberries, strawberries, parsley and lettuce with sodium hypochlorite at 50 ppm, 
showed 2 log PFU/ml reduction of MNV-1 in blueberries and less than 1 log PFU/ml 
reduction on strawberries and lettuce (54). MNV-1 was reduced by approx. 3, 3.5 and 
4.5 log PFU/ml on blueberries, strawberries and lettuce, respectively with PAA and 
Felcone at 85 ppm of peroxyacetic acid for 1min, whereas there was a reduction of 
about 3, 2.5 and 2.5 log PFU/ml when only PAA at 85 ppm was used on blueberries, 
strawberries and lettuce, respectively. The researchers did not show a significant 
reduction of MNV-1 (<0.5 log PFU/ml) with aq. chlorine dioxide at 20ppm of free 
chlorine on any of the food matrices, whereas there was a slight reduction (~1 log 
PFU/ml) on using chlorine dioxide with Feclone (54). When FCV-F9 was treated with 
hypochlorite solution for 1min at room temperature in pollyalomer ultracentrifuge 
tubes, 1.75, 0.75, 1.5, 2.5 and 5 log TCID50/ml reduction at 5000ppm was observed 
(40). Therefore, though chlorine and chlorinated compounds can reduce viral titers on 
surfaces, they are known to form carcinogenic by-products with organic matter (37) 
and hence alternative techniques need to be further studied. 
2.1.6 NaCl 
The antimicrobial effects of fermented foods are attributed to the low pH produced by 
lactic acid and bacteriocins such as niacin as well as to other factors such as salt 
concentration, temperature, and curing time. Salt lowers the pH and is supposed to 
denature capsid protein, and inactivates the virus through binding and subsequent 
denaturation of  nucleic acid (110). When MNV-1 (at initial titer of 6.39-6.43 log PFU/g) 
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was spiked on oysters using 5 and 10% NaCl and fermented for 18 hours up to 15 
days, the MNV-1 titers decreased from 6.44 log PFU/g to 5.76 log PFU/g at 3 days 
post fermentation (DPF) and reached a minimum of 4.84 log PFU/g at 15 DPF (108). 
Whereas 10% NaCl reduced MNV-1 titers from 6.44 log PFU/g at 0 DPF to 5.90 log 
PFU/g at 3 DPF and 5.45log PFU/g at 15 DPF while the LAB populations increased 
from 3.11 log CFU/g to 6.29 log CFU/g at 7 DPF and 6.96 log CFU/g at 15 DPF (104). 
FCV-F9 was reduced by 0.5 log TCID50/ml at 0.1% lactic acid (pH 6) after 3 hours at 
both 4 and 20°C, while this reduction increased to 1.5 log TCID50/ml at 0.4% lactic acid 
(pH 3.2) after 3 hours at 20°C, and 0.9 log TCID50/ml reduction at 4°C (114). When 
NaCl was used for treatment of FCV-F9, reduction of 0.2 log TCID50/ml at 2% NaCl at 
both temperatures was reported, while around 0.6 and 0.2 log TCID50/ml reduction at 
20% NaCl at 20 and 4°C, respectively after 3 h was obtained (110). Therefore, change 
in pH or salt concentration shows reduction in titers of HNoV surrogates such as MNV-
1 and FCV. 
2.2 Ultraviolet light (UV) 
UV light has been approved by the US FDA for treatment of food at 2,537 A 
intensity of radiation for control of surface microorganisms and for sterilization of water 
used in food production (US FDA 21 CFR Part 179.39). UV at higher doses of 1,000 
mW s/cm2 is proposed to affect the viral capsid proteins, thereby making the genome 
susceptible to RNase enzymes (49, 106). Although it has minimal detrimental effect 
on nutrient content in food and has low installation cost, but it has a disadvantage of 
shallow penetration depth on food surfaces (79). 
UV treatment of 320μl aliquots of PBS-diluted HNoV GII.4 virus stock in 90 mm 
Petri dishes resulted in the RCVGS reduction from 3.26 to 2.96, 2.45, 1.54, −0.37 and 
−0.37 log at 250, 500, 750, 1000, and 1500 mJ/cm2 UV radiation, respectively (127). 
When MNV-1 at 50 μL was deposited on either the skin or the calyx tissue of 
blueberries and treated with UV directly (dry UV treatment) or immersed in agitated 
water during the UV treatment (water-assisted UV treatment) for 1–5 min at 10 
mW/cm2, MNV-1 titers were reduced from 7 log PFU/sample to non-detectable levels 
(79) with water-assisted UV and 10-ppm chlorine treatment after 2-min treatment. 
Water wash alone for 5 min was reported to be achieve only a 1.73 log reduction of 
MNV-1. MNV-1 was reduced by 2.43, 2.48 and 3.04 log PFU/sample after 1, 2 and 
5min respectively using dry UV and using water assisted UV, reductions were 3.23, 
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4.32 and 4.36 log PFU/sample after 1, 2 and 5min respectively, respectively (81). 
When wash water with added blueberry juice (2%) for 2min UV+chlorine (10ppm) 
treatment, a reduction greater than 3.51 log PFU/sample was obtained (79). UV 
exposure reduced MNV-1by 0, 0.1, 0.3, 2, 2.3, 2.5, 2.9, 3.7, 3.9, 4.2 and 4.4 log at 10, 
20, 30, 40, 50, 60, 90, 120, 180, 240 and 300 mWs/cm2 of UV exposure, respectively 
(93). UV treatment at 254nm at room temperature showed 99% inactivation of FCV-
F9 at 16 and 13 mJ/cm2 UV dosage in buffered demand free (BDF) and ground water 
respectively, whereas 55mJ/cm2 UV dose was required for 99% inactivation of MS2 in 
BDF water (122). MNV-1, FCV-F9 and MS2 at an initial titer of 8, 8.5 and 10 log 
PFU/ml respectively could be reduced by 4 log using 25, 29 and 70 mJ/cm2, for MNV-
1, FCV-F9 and MS2, respectively (Table 1.3-7) (90). Lettuce, strawberries and green 
onions infected with FCV-F9 at an initial titer of 7 to 9 logTCID50/ml treated with UV at 
240 mW s/cm2 (49), showed reduction of 4.5 to 4.6, 2.5 to 5.6 and 1.9 to 2.6 log 
TCID50/ml on lettuce, green onions and strawberries, respectively (49). 
 
2.3 Ozone 
 Ozone is attractive for use in the food environment because it naturally 
decomposes to elemental oxygen, is a very powerful oxidant, and has high 
penetrability and reactivity (95). Ozone (O3) is a triatomic oxygen molecule that exists 
as a bluish gas with a strong characteristic odour with antimicrobial activity against 
bacteria, fungi, spores, protozoa, and viruses (4, 95). It is known to directly disrupt 
various cellular constituents such as proteins, nucleic acids and virus capsid 
components (95, 129). Buffered-demand free water inoculated with FCV-F9 and 
treated with 1mg/ml ozone for 0.25 and 1.2min at pH 7 at 5°C.showed 4.28 and >4.7 
log TCID50/ml reduction in titer, respectively whereas 1.85 and 2.77 log TCID50/ml 
reduction was obtained at 0.06 mg/ml ozone after 0.25 and 5min, respectively (121). 
Alfalfa seeds (1g per sample) inoculated with 500 µl MNV-1 at an initial titer of 6.66 
log PFU/ml and dried for 60 min at 22°C in a biosafety cabinet,after 0.5 min of aqueous 
6.25 ppm ozone treatment, showed an immediate loss of >4 log PFU, with increased 
reduction of 5.6 log PFU after 30 min, and reduction of 4.04, 4.27, 4.56, 4.90 and 5.60 
log PFU/g of seed after 0.5, 1, 5, 15 and 30 min, respectively (129). Treatment of liquid 
MNV-1 stocks with gaseous ozone at 6% wt/wt ozone in oxygen created by corona 
discharge from extra dry compressed purified (99.6%) caused reduction of 4.1 log 
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PFU/ml after 10 min and reduction to non-detectable levels after 40min, while glass 
and stainless steel surfaces inoculated MNV-1 still had 2.5 log PFU/ml viral titer left 
after 40 min treatment (95). Inoculated onions treated with bubbling gaseous ozone 
from an ozone generator at 6.25 ppm for 10min caused MNV-1inactivation of 1.5 and 
2.5 log PFU/plant after 10min at 20°C for internalized and external MNV-1(60). Ozone 
treatment shows effective inactivation of HNoV surrogates, but with a long exposure 
time, which necessitates the search for alterative inactivation techniques. 
2.4 High hydrostatic pressure 
High hydrostatic pressure (HHP) is used for non-thermal processing of food 
products such as oysters, guacamole, fruit jams, ready-to-eat meats, salsa, and 
orange juice (76). A possible mode of action is the loss of receptor-binding function of 
the virus(80, 118). High hydrostatic pressure controls or reduces contamination from 
foodborne pathogens with minimal impact on the taste, texture, appearance and 
nutritional value of food, (76). The efficacy of high hydrostatic pressure (HHP) on virus 
inactivation depends on pressure level (directly related), treatment time (directly 
related), treatment temperature, pH of substrates and the virus type (76). 
Previously, Lou et al, (80) showed that a 600-MPa treatment was able to destroy MNV-
1 capsid integrity using transmission electron microscopy Strawberry purees (one-
gram samples) inoculated with 10 μl of the HNoV GI.1 or GII.4 treated at 450, 500 and 
550MPa high hydrostatic pressure (HHP) for 2min at initial sample temperatures of 0, 
4 and 20°C, showed reduction of approx. 1.5, 2.5 and 3 log genomic copies/g (gc/g), 
respectively at 0°C; 1.25, 2.2 and 3 log gc/g, respectively at 4°C and 0.75, 1 and 1.5 
log gc/g, respectively at 20°C (63).  HNoV GI.1 strain on blueberries was shown to be 
reduced by 3.2 log gc/g at 550 MPa (HHP) after 2 min, while HHP treatment at 650 
MPa caused only 1.7 and 2.5 log gc/g reductions of GI.1 strain on strawberry quarters 
and raspberries, respectively while for HNoV GII.4 strain on strawberry quarters, 650 
MPa caused reduction of 3.1 log gc/g (61). 
HNoV GII.4 and GI.1 treated with HHP at 200-550 MPa at 1, 4, 10, 21 and 35°C 
for 2min (76), showed no reduction at 21 and 35°C, but >3 and 1.8 log RNA level 
reduction at 1 and 4°C, respectively was obtained for GI.1 (76). Similarly, for GII.4 
strain at 250 MPa at 21 and 35°C showed no reduction, but caused >2 log RNA level 
reduction at 1 and 4°C (76). HNoV GII.4 at 1°C was shown to be reduced by 2.9 log 
RNA level reduction with 250 MPa HHP while GI.1 had 1.7 log RNA level reduction 
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with 400 MPa HHP (76). HHP at 500 MPa and 21°C for 2 min was reported to result 
in reduction of 2.3-log RNA level of GI.1 RNA at neutral pH and a 0.4-log RNA level 
reduction at pH 4 while there was 3 and 1.5 log RNA level reduction of GI.1 strain at 
550 MPa at neutral pH and pH 4, respectively (76). While 350 MPa at 21°C for 2 min 
was shown to result in 3.8 log RNA level reduction of GII.4 at neutral pH and a 1.2-log 
reduction at pH 4, and 550MPa reduced GI.1 by 3.75 and 1.25 log RNA level at neutral 
pH and at pH 4, respectively (76). Inoculated HNoV GI.1 in blueberries in dry state at 
1°C was shown to be reduced by 0.5 and 0.9 log RNA level at 500 and 600 MPa, 
respectively. While in wet state 0.5 and 2.7 log RNA level reduction at 500 and 600 
MPa, respectively at 1°C was obtained while there was 0.5 and >3 log RNA level 
reduction in wet state at 21°C at 500 and 600 MPa. This shows that the efficacy of 
HHP increased with decreasing temperature for both GII.4 and GI.1 strain (76). 
 HNoVGI.1 and GII.4 inoculated into oysters and treated with HHP at 350 and 
500 MPa at 0°C were reported to be reduced by 4 log RNA level as determined by 
PGM-MB RT-PCR, while there was no significant change colour or texture of oyster 
tissue (136). Using RT-PCR, 3.2 and >4 log reduction in RNA level of HNoV GII.4 at 
300 and 350 MPa, respectively at 0°C for 2 min was reported, while HNoV GI.1 
showed 3.2 and >4 log RNA reduction at 450 and 500 MPa, respectively at 0°C for 2 
min (137). In another study, HNoV GI.1 and GII.4 HNoV inoculated into oyster 
homogenates showed >4 log reduction in RNA level of both GI.1 and GII.4 at 600MPa 
at 6°C, and 0.7 and 1.3 log reduction in RNA level of GI.1 at 300 and 400MPa, 
respectively at 6°C and 2.9 and 3.6 log reduction in RNA level of GII.4 at 300 and 
400MPa, respectively at 6°C. At 25°C, they found similar reduction of 1 and 3.6 log in 
RNA level of GI.1 and GII.4, respectively at 400 MPa (136). HNoV GI.1 at initial 
concentration of 7.2X108 genomic equivalent copies (GEC) was inoculated at 1.0X104 
GEC in oysters (73) and treated with HHP at different pressures and subjects were 
challenged with the treated oysters and controls (76). Using RT-PCR none of the 10 
subjects challenged with HNoV-seeded oysters treated by 600 MPa at 6°C for 5 min 
were shown to be infected with HNoV, whereas 400MPa at both 4 and 25°C resulted 
in positive infection of subjects (73). MNV-1 min (at an initial titer of 5.8±0.2 log 
PFU/blueberry) when pressurized at 350 and 400 MPa at 21°C for 2 min in wet state 
showed >5.6 log reductions of MNV-1, but almost no reduction was achieved at 35°C 
when treated at 400 MPa, while MNV-1 was below detection limit when treated at 
350MPa and 400MPa for 2min at 4°C (77). 
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FCV-F9 was shown to be reduced by 5 and 4 log PFU/ml at 200 MPa at -10 
and 50°C, respectively after 4 min, with a 4 log PFU/ml reduction after 7 min at 59.3°C 
and a reduction of 2.8 log PFU/ml at 200 MPa for 20 min at 21°C (67). MNV-1 in cell 
culture media when subjected to pressure range of 350 to 450 MPa for 5-min at 20°C 
(67) showed that 450-MPa treatment was sufficient to inactivate 6.85 log PFU of MNV-
1. Furthermore, a 5-min pressure treatment of 350 MPa at 30°C inactivated 1.15 log 
PFU/ml of virus titer, while the same treatment at 5°C resulted in a reduction in virus 
titer of 5.56 log PFU/ml (67). 
 
2.5 Irradiation 
Irradiation causes nucleotide degradation through production of oxygen and 
hydroxyl radicals which interact with cellular genetic material (92). Doses of up to 4.0 
kGy to control foodborne pathogens in fresh iceberg lettuce and spinach and 7 kGy 
for frozen meat is approved by FDA (50). 
At a dose of 2.8 kGy, VLPs were found to be clumped together, along with 
altered morphology (45). With an increased dose of 5.6 kGy, large concentration of 
protein debris was reported to be obtained, and the structure of VLPs was destroyed 
and particles could not be seen after 22.4 kGy irradiation, concluding the absence of 
any small spherically structured VLPs (48). On analysis of irradiated VLPs by SDS-
PAGE, approx. 40 and 25% of HNoV VP1 protein remained after treatment at doses 
of 2.8 and 5.6 kGy, respectively (48). 
When MNV-1 was inoculated in 5.0 g of green algae, fulvescene sample to get 
a final titer of 5-6 log PFU/ml and exposed to 0, 3, 5, 7 or 10 kGy of gamma rays using 
a cobalt-60 gamma irradiator at 10 kGy/h,  titters of 1.78 (2.46 log reduction), 2.30 
(1.94 log reduction), 2.83 (1.41 log reduction), and 3.08 (1.16 log reduction), 
respectively were reported (92). On treatment of FCV-F9 and MS2 with gamma 
irradiation at 200 Gy, the researchers observed reduction in titer of 1.6 and 5-7 log 
TICD50/ml in case of FCV-F9 and MS2, respectively (36). Hence, irradiation is not as 
effective in reduction of titers of HNoV surrogates and alternate strategies need to be 
studied. 
E-beam: It is proposed to inactivate non-enveloped viruses by disrupting the 
viral structure, degrading the viral proteins, and degrading genomic RNA. Although it 
can be used for high-throughput products, but it has the disadvantage of having less 
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penetration effect as compared to gamma irradiation (140). It uses machine 
accelerated electrons for production of irradiation as opposed to gamma rays (96). 
The permissible limit provided by FDA is up to 4.0 kGy to control foodborne pathogens 
in fresh iceberg lettuce and spinach (50). 
Lettuce inoculated with FCV-F9 at initial titer of 7.6 log TICD50/ml  was reported 
to show 90% reduction of FCV-F9 titer on lettuce required 2.95 kGy dose at 4°C (140). 
MNV-1 virus stock (at 6 log PFU/ml) showed a reduction of 1.6 and 1.2 log PFU/ml of 
MNV-1 in phosphate buffered saline (PBS) and Dulbecco's Modified Eagle Medium 
(DMEM) with e-beam doses of 4 kGy (96). MNV-1 was also shown to have 0.5 log 
PFU/ml of virus remaining in PBS at 16.9 kGy, 0.8 log PFU/ml of virus remaining in 
DMEM at 26.5 kGy, whereas it was not detectable in media or PBS after treatment of 
26.5 to 32.7 kGy (96). 
TV (initially at 6.6 log PFU/ml) in solution in cell culture media was reported to 
be reduced to 3.2 and 1.8 log PFU/ml after treatment with 8.6 and 16.9 kGy e-beam. 
In case of lettuce and strawberries inoculated with TV (at initial titer of 3.7 and 4.4 log 
PFU/ml, respectively), the final titer after treatment with 8.7 kGy e-beam was reported 
to be non-detectable for lettuce and 1.8 log PFU/ml for strawberries (96). This shows 
that e-beam was more effective in reducing the virus in food matrix as compared to 
cell culture media, but the dosage required for reduction of TV to non-detectable level 
was higher (8.7 kGy for lettuce and 16.9 kGy for strawberries) than permissible limits 
approved by FDA (96). 
2.5.1 Pulsed light 
Pulsed light treatment has shown to be effective for inactivating bacteria, fungi, and 
yeasts in water and foods and in diagnostic laboratories (125). Besides, the 
advantages include speed and cost-effectiveness, as it does not require the addition 
of any chemical product (125). This technology is based on very short, high-intensity 
pulses of white light, from UV-C to near infrared, and according to the FDA, pulsed 
light may be safely used for the decontamination of food and food contact surfaces by 
using a xenon lamp emitting wavelengths between 200 and 1,000 nm, pulse durations 
not exceeding 2 milliseconds, and cumulative intensity less than 12 J/cm2 (50). On 
pulsed light inactivation of MNV-1 on polyethylene disks, the reduction increased from 
around 0.5 to 4 log PFU/ml as fluence increased from 0.69 to 8.98 J/cm2 at 80mm 
from xenon lamp (125). While on polyvinyl chloride disks, the reduction of MNV-1 
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increased from 0.5 to 3.5 log PFU/ml and on stainless steel disks it increased from 0.5 
to 2.5 log as fluence increased from 0.69 to 8.98 J/cm2 (125).  
2.6 Cold Plasma 
Cold atmospheric pressure plasma (CAPP) generated by applying an electrical 
field to an initially electrically neutral gas consisting of nitric oxide and reactive oxygen 
species is known to have anti-bacterial anti-fungal properties, and also has been 
shown to inactivate HNoV GII.4 virus particles (3). It is proposed that the oxidation of 
viral capsid proteins by plasma-produced reactive oxygen and nitrogen species could 
be responsible for antiviral action of CAPP (1). It is used for preservation in meat, 
poultry, fruits and vegetables industry as it shows reductions of greater than 5 logs for 
bacterial pathogens with treatment up to 120s (83). Although it shows antimicrobial 
action at short treatment time, it has several disadvantages such as complexity of 
equipment and cost, unexplored sensory and nutritional impact on food products (83). 
HNoV GII.4 (at an initial load of 2.4X107 virus particles per ml) after exposure 
to cold plasma was found to be reduced by1.23 and 1.69 log after 10 and 15 min, 
respectively (3). Furthermore, at an initial titer of 1.1X103 genomic equivalents/ml and 
3.67X101 genomic equivalents/ml, they showed 10 fold reduction in viral load after 
CAPP exposure for 2 min and 1 min, respectively (3). To analyze the effect of cold 
gaseous plasma, FCV-F9 was exposed to Argon atmospheric plasma generated at 1, 
1.5, 2, 2.5 and 3 W up to 180 s (1), that led to gradual reductions in the FCV-F9 titer 
ranging from 0.33 to 2.66, 0.66 to 4.00, 0.88 to 4.66, 0.99 to 5.55, and 1.11 to 5.55 
logTCID50/0.1 ml, respectively while they showed complete reduction after exposure 
to 2.5 and 3W plasma for 120 s (1). Although CAPP treatment shows titer reduction of 
HNoV surrogates, it has certain disadvantages such as high cost, uncertainty of 
sensory and nutritional impact in food matrix, complexity of equipment. Therefore, 
there is a need to search for alternative inactivation techniques. 
2.7 Ultrasound 
Ultrasound are sound waves with frequency higher than 20 kHz whereas high intensity 
ultrasound has frequency range of 20 kHz - 2 MHz and causes microbial inactivation 
by shearing the cell wall, disrupting the cell membrane and damaging the DNA through 
the production of free radicals (42, 114). FCV-F9, MNV-1 and MS2 at an initial titer of 
4 log PFU/ml in PBS when subjected to ultrasound treatment at 20 kHz was reported 
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to show reduction to non-detectable levels of FCV-F9, MS2 and MNV-1 after 5, 10 and 
30 min, respectively (114). Whereas, in orange juice, FCV-F9 showed complete 
reduction after 15 min while MNV-1 showed only 1.55 log reduction after 30 min with 
what treatment time, temperature (114). Therefore, ultrasound only showed minimal 
reduction of HNoV surrogates even at long exposure time, necessitating the need for 
alternative inactivation technique. 
2.8 Antimicrobials 
Grape seeds, the by-products of wine and the grape juice industries, contain 
large quantities of phenolic compounds as well as dimeric, trimeric, and proantho-
cyanidins (PAC) or condensed tannins (64). It has been considered as a generally 
regarded as safe (GRAS) by the U.S. Food and Drug Administration (sections 201(s) 
and 409 of the Federal Food, Drug, and Cosmetic Act). It inhibits viral replication for 
enveloped and non-enveloped virus by blocking the virus binding to the host cell 
receptors or by coating the virus to prevent attaching to the host-cell or by causing 
clumping of viral particles (64). 
HNoV in lettuce extract was found to be reduced by approx. 0.5 and 1.5 log 
genomic copies/ml after treatment with 0.2 and 2 mg/ml GSE (76). Similarly in 0.01% 
milk, reduction of approx. 1 and 1.25 log genomic copies/ml of HNoV GII.4 with 0.2 
and 2 mg/ml GSE was reported, while in the case of 0.1% milk there was no reduction 
with 0.2 mg/ml GSE but a reduction of 1.25 log genomic copies/ml HNoV GII.4 for 
2mg/ml GSE (76). In PBS, HNoV GII.4 was reduced by 1 and 2 log genomic copies/ml 
at GSE concentrations of 0.2 and 2 mg/ml, respectively (75). 
GSE at 0.25, 0.5, and 1.0 mg/ml GSE has been shown to reduce MNV-1 (at 5 
log PFU/ml) by 1.49, 1.72, and 1.97 log PFU/ml at 37°C for 2 h, whereas the reduction 
at same concentrations at room temperature were 1.37, 1.48, and 1.67 log PFU/ml 
(112). At 37°C, 0.25 mg/ml GSE reduced FCV-F9 titers by 0.26, 0.31, 0.34, 0.46, 
1.73 log PFU/ml after 5, 10, 15, 30 min and 1 h, respectively, and to undetectable 
levels after 2, 6, and 24 h (66). GSE at 1 and 2 mg/ml in apple juice (AJ) was reported 
to reduce FCV-F9 titers to undetectable levels after 5 min, while GSE at 2, 4and 8 
mg/ml in 2% milk at 37°C showed 0.92, 0.96 and 1.07 log PFU/ml reduction of FCV-
F9 respectively. MNV-1after 30min treatment with GSE at 1, 2 and 4mg/ml in AJ at pH 
3.6 was reduced to undetectable levels, while GSE with 2% milk showed no reduction 
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in MNV-1 titer even after 24 h (64). Hence, it can be seen that grape seed extract has 
the potential for reduction of HNoV surrogates but with long treatment time. 
Natural extracts such as essential oils or their main compounds, categorized as 
Generally Recognised as Safe (GRAS), are potential alternatives to chemical 
preservatives, that can possess antibacterial, antifungal, insecticidal, pesticidal, 
antitoxigenic, antiviral and anti-parasitic activity (102). They are extracted by hydro-
distillation of plants that are rich in sources of biologically active compounds, such as 
phenolic acids and terpenoids (101). Carvacrol, a monoterpenic phenol, is the primary 
component of oregano essential oil, with reported antimicrobial activity against a wide 
range of food spoilage or pathogenic fungi, yeast and bacteria (101). It shows antiviral 
activity by altering the capsid integrity and by preventing adsorption of the virus to host 
cells (52). Carvacrol at 0.25, 0.5 and 1% was shown to reduce MNV-1 (initial titer 5.7 
log TCID50/ml) by 1.86, >3.57 and >3.57 logTCID50/ml, respectively and FCV-F9 by 
3.41, >4.53 and >4.53 log TCID50/ml, respectively after 2 h at 37°C in suspension 
(101). When MNV-1 (initial titer 106 TCID50/ml) was treated with 4% oregano oil or 
0.5% carvacrol (v/v) for up to 24 hours, >3.27 log reduction in MNV-1 titer after 1 and 
2 h with carvacrol at 0.5 and 0.25%, respectively was obtained (52). Treatment of 
MNV-1-1 with 0.5, 1 and 2% oregano oil for 2h at 37°C was reported to show 1.04, 
1.17 and 1.62 log TCID50/ml reduction while there was 1.38, 2.46 and 3.75 log 
TCID50/ml reduction for FCV-F9 (44). MNV-1 (at initial titer of 6.07 TCID50/ml) with 
thymol, one of the main components of oregano, at 0.5, 1 and 2% showed a 0.5, 1.66 
and 2.45 log TCID50/ml reduction in suspension at 37°C after 2 h (102). Treatment with 
clove essential oil (EO) at 0.1, 0.5 and 1% at 37°C was reported to cause reductions 
of MNV-1 by 0.42, 0.5 and 0.67 log TCID50/ml at 37°C, respectively and 0.96, 0.58 and 
0.83 log TCID50/ml reduction at 4°C, whereas for FCV-F9 reduction of 0.92, 2.26 and 
3.75 log TCID50/ml at 37°C and 0, 0.25 and 0.04 log TCID50/ml at 4°C was obtained 
(44).  
Zataria essential oil at 0.01, 0.04, 0.08 and 0.1%, caused MNV-1 reductions of 
0, 0, 0.55 and 1.01 log TCID50/ml at 4°C respectively, and reduction of 0.04, 0.54, 0.29 
and 0.25 log TCID50/ml at 37°C, whereas for FCV-F9 reduction of 0.13, 1.04, 1.91, 
4.17 and 4.51 log TCID50/ml at 37°C and no reduction at 4°C was reported (44). 
Lemongrass oil, citral (one of the main components of lemongrass oil) and allspice oil 
(68.6% eugenol (41)) at 2 and 4% (vol/vol) treatment of MNV-1 (at initial titer of 6 log 
TCID50/ml) was reported to cause reduction of 0.38, 0.74 and 2.19 log TCID50/ml after 
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0.5, 6 and 24 hours with 2% lemongrass oil, respectively, whereas 4% lemongrass oil 
reduced MNV-1 by 0.59, 0.9 and 2.74 log, respectively after 0.5, 6 and 24 hours (53). 
Citral contains two isomeric acyclic monoterpene aldehydes, geranial and neral. Citral 
at 2% was able to reduce MNV-1 by 0.67, 1.4 and 2.4 log TCID50 after 0.5, 6 and 24 
h, respectively and 4% showed reductions of 0.7, 1.88 and 3 log after these time 
intervals, respectively (53). 
Seeds and pericarp of Zanthoxylum schinifolium, which belongs to the 
Rutaceae family, are widely consumed in Korea, China, and Japan as a spice and in 
folk medicine as an antimicrobial and antioxidant for the treatment of vomiting, 
diarrhea, and abdominal pain (44). Post treatment with Z. schinifolium seed oil at  
0.01% after 1 h at 37°C, showed 70% and 20% inhibition in plaque formation ofFCV-
F9 and MNV-1, respectively (87). Thyme EO, which is extracted from Thymus vulgaris 
of the mint family, at 2% has been reported to reduce MNV-1 by 0.5 log TCID50/ml 
after 1 h at 37°C, whereas 2% oregano EO and Mint EO were shown to reduce MNV-
1 by 0.75 and 0.87 log TCID50/ml at the same time temperature conditions (43). 
Cranberry has historically been used by native Americans for treating bacterial 
infections. MNV-1 was shown to be reduced by 1.90, 1.66, 2.24 and 2.94 log PFU/ml 
after treatment for 1 h at room temperature with cranberry juice (CJ) at pH 2.6, CJ at 
pH 7.0, 0.15 mg/ml polymeric proanthocyanidins (PAC) and 0.30 mg/ml PAC, 
respectively (113). Pomegranate juice and 6 mg/ml pomegranate polyphenols (PP), 
has been reported to reduce MNV-1 by 1.32 and 3.61 log PFU/ml, respectively with 
one hour at room temperature (113). Black raspberry juice at 3% concentration has 
been reported to show 43% and 58% inhibition in viral replication of MNV-1 at co-
treatment and posttreatment for one hour at 37°C (86). Therefore, natural extracts 
have the potential for inactivation of HNoV surrogates, but a long treatment time is 
required. 
2.9 Heat 
One of the most successful inactivation strategy/approach is thermal 
inactivation. Heat disrupts the hydrogen bonding and destroys the spatial relationships 
necessary to maintain the structural integrity of viral proteins (22) thereby leading to 
denaturation of viral proteins as well as destruction of virus particles into non-infectious 
viral subunits and single proteins and releasing RNA or denaturing RNA (107). During 
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thermal processing, heat inactivation kinetics (D- and z-values) are used to determine 
adequate processing to ensure food safety. 
The D-value is defined as the time at a given temperature necessary to reduce a 
microbial population present in a defined medium by 90% and is indicative of the 
thermal resistance of a microorganism at a constant temperature (19). The z-value is 
the change in temperature required to increase or decrease the D-value by 90% and 
is indicative of the temperature dependence of microbial inactivation (19). Industrially, 
often six log reduction is used for processes such as pasteurization. This is 
represented by  the 6D- value (19). HNoVGI.1 samples heated in a thermocycler at 
99°C for 5 min showed 1.77 and 1.73 log reduction in genomic copies/ml (gc/ml) after 
thermal inactivation with and without RNase A treatment respectively. Similar 
reductions of 1.71 and 1.56 log gc/ml were obtained with and without RNase A 
treatment for what HNoV GII.4 (6). 
Artificially contaminated oysters with HNoV GII.4 VLPs at 4log RNA copies/ml 
were investigated for HNoV ability to bind to porcine gastric mucin conjugated to 
magnetic beads (PGM-MBs), after heating at 80°C for 10, 30, 60s, or 5min, or at 100°C 
for 5s in a capillary tube sealed with a vinyl plastic cover followed by rapid cooling in 
ice (6). The researchers found that at 80°C after 5min there was a slight reduction in 
protein density of the VLPs binding to the PGM-MBs as compared to original input 
VLPs and they completely lost their ability to bind after treatment at 100°C for 5s (6). 
Wang et al treated HNoV at different conditions including heat treatment of 300 
μl aliquots of PBS-diluted virus stock in 1.5 ml microcentrifuge tubes at 56, 63, 72, and 
100°C up to 60 min (127). They showed by using in situ capture qRT-PCR that 
treatment for 2 min at 100°C resulted in the complete loss of HNoV RCVGS whereas 
treatment after 2min at 72°C showed only 0.60 to 1.04 log reductions, while a complete 
loss of the RCVGS could be observed at 4 min and longer. Treatment at 63°C also 
resulted in a time-dependent loss of HNoV RCVGS, but a 60-min treatment only 
achieved a 1.37 log reduction (127). 
The protruding (P) domain of VP1 (major structural protein) of NoV capsid when 
expressed in Escherichia coli forms subviral particles, the P particles (74). P particles 
from several HNoV strains (GII.4, GII.9, GI.4, GI.1) were subjected in parallel to critical 
heat treatment (60°C for 30 min and 70°C for 2 min) and harsh heat treatment (85°C 
for 2 min) (74). GII.4 was found to be the most resistant to critical heat treatment and 
GII.9 was found to be the most resistant to harsh heat treatment while HNoV GI.1 was 
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found to be the most sensitive one to all the tested heat treatments of the four norovirus 
strains studied (74). HNoV GII.4 extracted from positive stool samples at initial 
concentration of 4 to 5 log RT-QPCR copies was subjected to heat inactivation for 
2 min at different temperatures from 20 to 90°C in thin walled PCR tubes in a thermal 
cycler (124). On measuring % survival of Taqman RT-QPCR target following RNAse 
treatment HNoV showed 60% survival at 60°C for 2min  and was reduced to 0% after 
80°C for 2min (124). 
Brie et al, 2016 showed that when MS2 was exposed to 72°C, the particles were 
disrupted and the genome became susceptible to degradation by RNases (25). When 
MS2 at an initial concentration of 10 log PFU/ml was heated at 72°C in thin-walled, 
500-μl tubes in a PCR thermocycler and 30 W UV for 1 to 4 min (94), the first-order 
rate for enzymatic treatment qPCR was 5.2 ± 1.3 min−1 and 2.5 ± 0.04 min−1 for heat 
and UV treatment respectively giving 8.6 and 8.7 log PFU/ml loss in infectivity (94). 
 The D-values calculated from the first-order model (50 to 72°C) ranged from 
0.21 to 19.75 min for FCV-F9, 0.25 to 36.28 min for MNV-1in 2-ml GLASS vials in cell 
culture media using a circulating water bath (18). There have been various studies for 
determination of D and Z-values of HNoV surrogates in food matrices (Table1.7-1.12). 
In blue mussels, the D-value at 50 to 72°C in 2ml vials was reported to be 0.07 - 5.2 
min for FCV-F9 and 0.18 – 20.9 min for MNV-1 using the first order model (19). 
Whereas in turkey deli meats, the D-values calculated using first order model ranged 
from 0.1 – 9.9 min for FCV-F9 and 0.2 – 21 min for MNV-1 in vacuum bags at a 
temperature range of 50 to 72°C (22).For spinach, the D values at 50 to 72°C in 2ml 
vials ranged from 0.15 – 17.39 min for FCV-F9 and 0.16 – 14.57 min for MNV-1 (18). 
However, HAV showed the most resistance to heat when compared to MNV-1 or FCV-
F9, with D-values of 56.2, 8.4 and 2.67 min in 2-ml glass vials with cell culture media 
(19) and 42, 20.6 and 5.9 min for turkey deli meat in vacuum bags (21), 34.4, 8.43 and 
4.55 min for spinach in vacuum bags (24) at 50, 56 and 60°C. 
 TV has reported D-values of 11.8, 2.6 and 5.3 min in cell culture media in 
microcentrifuge tubes using tissue culture infectious dose (123) and 4.03, 1.18 and 
0.24 min using plaque assay (7) at 56, 63 and 72°C, respectively. Others have shown, 
1.79, 1.83, 2.9 and 3.07 log PFU/ml reduction in TV titer when heated at 50, 55, 60 
and 65°C, respectively in 0.2 ml PCR tubes for 2 min (59) (Table 1.13). AiV (initially at 
7 log PFU/ml) is reported to be more resistant than MNV-1 or FCV-F9 showing 4 and 
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5 log reduction after 10 and 20 min in microcentrifuge tube in cell culture media at 
56°C (33). 
Based on the information available to-date on the thermal inactivation kinetics of 
foodborne viruses (Table 1.7-12), research is on-going in the search for potential 
surrogates for HNoV. Furthermore, there have been only a few studies done for 
determining thermal inactivation behavior of AiV in cell culture media and to our 
knowledge no reported studies are present on thermal inactivation kinetics of TV in 
food matrices have been reported to date.  
Therefore, the objectives of this research were to: 
1) To determine heat inactivation kinetics of Tulane virus (as a cultivable human 
norovirus surrogate) in cell culture media in 2 ml glass vials and spinach in vacuum 
bags. 
2) To determine heat inactivation kinetics of Aichi virus in cell culture media in 2 ml 
glass vials.  
Based on these results, potentially appropriate thermal processing parameters to 
inactivate foodborne viruses can be designed. 
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4 APPENDIX 
Tables 
Table 1.1 Recent outbreaks of HNoV worldwide 
 
Year State Deaths Food Vehicle/ 
Contamination source 
Reference 
2015 Kansas 1 Not specified CDC, 2016 
2015 Ohio 3 Homemade potato salad, 
Beef 
CDC, 2016 
2015 North Carolina 1 Pork CDC, 2016 
2015 Florida 1 Raw oysters CDC, 2016 
2015 Utah 1 Not specified CDC, 2016 
2015 US (multistate) 13 Pre-packaged lettuce, 
cucumber 
CDC, 2016 
2015 Belgium - Healthcare facility (100) 
2014 New York 2 Not specified CDC, 2016 
2014 US (multistate) 2 Mung bean sprouts CDC, 2016 
2014 US (multistate) 7 Caramel apple CDC, 2016 
2013 Rhode Island 2 Not specified CDC, 2016 
2012 California 4 Soup, mushroom CDC, 2016 
2012 US (multistate) 3 Cantaloupe CDC, 2016 
2012 US (multistate) 5 Ricotta salata cheese CDC, 2016 
2011 Rhode Island 2 Not specified CDC, 2016 
2011 Oregon 2 Strawberries CDC, 2016 
2011 US (multistate) 33 Cantaloupe CDC, 2016 
2011 Norway - Not specified (55) 
2011 France - Pasta, raw vegetables (81) 
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Table 1.2 Non-thermal inactivation of MNV 
Treatment Matrix Conditions Log Reduction Units Ref 
UV Cell culture 10 mW/cm2, 2min ND PFU/ml (79) 
Blueberries 10 mW/cm2, 5min 1.73 
10 mW/cm2, 1min 2.43 
10 mW/cm2, 2min 2.48 
10 mW/cm2, 5min 3.04 
Ozone Alfalfa seeds 6.25 ppm, 22°C, 0.5 min 4.04 PFU/g (129) 
 
Cell culture 6.25 ppm, 22°C, 1 min 4.27 
 
Green onions 6.25 ppm, 22°C, 5 min 4.56 
 
Internalized 6.25 ppm, 22°C, 15 min 4.9 
 
Green onions  6.25 ppm, 22°C, 30 min 5.6 
 
external 6% wt/wt, 10 min 4.1 PFU/ml (95) 
  
6.25 ppm, 20°C, 10 min 1.5 PFU/plant (60) 
   
2.5 
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Table 1.2 Continued 
Treatment Matrix Conditions Log Reduction Units Ref 
Pulsed 
light 
Cell culture polyethylene disks, 0.69 J/cm2 0.5 PFU/ml (125) 
polyethylene disks, 8.98 J/cm2 4 
polyvinyl chloride disks, 0.69 J/cm2 0.5 
polyvinyl chloride disks, 8.98 J/cm2 3.5 
stainless steel disks, 0.69 J/cm2 0.5 
stainless steel disks, 8.98 J/cm2 2.5 
Ultrasound Orange juice 20kHz, 30 min 4 PFU/ml (114) 
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Table 1.3 Non-thermal inactivation of HNoV 
 
Strain Treatment Conditions Reduction Units Ref 
HNoV 
GII.4  
UV 250 mJ/cm2  3.26 log RCVGS (127) 
500 mJ/cm2  2.96 
750 mJ/cm2  2.45 
1000 mJ/cm2 1.54 
1500 mJ/cm2  -0.37 
NV 
8FIIa 
Ozone 0.37-mg/liter, pH 7, 5°C, 0s >4 genomic RNA (105) 
0.37-mg/liter, pH 7, 5°C, 20s >4.5 
HNoV 
GII.4 
Cold 
plasma 
cold atmospheric pressure plasma, 10 min 1.23 genomic 
equivalents/ml 
(3) 
cold atmospheric pressure plasma, 15 min 1.69 
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Table 1.4 Non-thermal inactivation of FCV 
Treatment Matrix Conditions Log Reduction Units Ref 
UV Cell culture 29 mJ/cm2 4 PFU/ml (90) 
Lettuce 40 mW s/cm2 3.48 TCID50/ml (49) 
Green onions 2.46 
Strawberries 1.13 
Lettuce 240 mW s/cm2 4.62 
Green onions 3.88 
Strawberries 2.28 
Ozone Buffered 
demand free 
water 
1 mg/ml, 0.25 min 4.28 
 
(121) 
1 mg/ml, 1.2 min >4.7 
0.06 mg/ml, 0.25 min 0.85 
0.06 mg/ml, 5 min 2.77 
Cold plasma Cell culture Ar atmospheric plasma, 180s, 1W 2.66 TCID50/0.1ml (1) 
Ar atmospheric plasma, 180s, 1.5W 4 
Ar atmospheric plasma, 180s, 2W 4.66 
Ar atmospheric plasma, 180s, 2.5W 5.55 
Ar atmospheric plasma, 180s, 3W 5.55 
Ultrasound Orange juice 20kHz, 5 min 4 PFU/ml (114) 
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Table 1.5 Non-thermal inactivation of TV 
 
Treatment Matrix Conditions Log 
Reduction 
Units Ref 
UV Cell culture 30 mJ/cm2  3 TCID50/ml (132) 
60 mJ/cm2  5.4 
Ozone Cell culture 6% wt/wt, 10 min 0.5 PFU/ml (95) 
6% wt/wt, 40 min ND 
Alfalfa seeds 6.25 ppm, 22°C, 0.5 min 1.66 PFU/g (129) 
6.25 ppm, 22°C, 1 min 2.03 
6.25 ppm, 22°C, 5 min 3 
6.25 ppm, 22°C, 15 min 3.45 
6.25 ppm, 22°C, 30 min 3.83 
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Table 1.6 Non-thermal inactivation of AiV 
 
Treatment Matrix Conditions Log Reduction Units Ref 
UV Cell culture 10 mW s/cm2 2 to 3 TCID50/ml (49) 
50 mW s/cm2 5 to 6 
75 mW s/cm2 6 to 7 
Lettuce 40 mW s/cm2 3.96 
Green onions 2.35 
Strawberries 1.53 
Lettuce 120 mW s/cm2 4.41 
Green onions 3.66 
Strawberries 1.6 
Lettuce 240 mW s/cm2 4.59 
Green onions 2.49 
Strawberries 1.87 
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Table 1.7 Heat inactivation parameters of HNoV in different matrices at different temperatures. 
 
Virus Temp 
(°C) 
Matrix Vessel Time 
(min) 
Log 
Reduction 
Unit Reference 
NoV 
GII.4 
56 Cell culture 1.5 ml 
microcentrifuge 
tube 
2  0.02 RCVGS (127) 
63 0.08 
72 0.6 
100 2.8 
NoV 
GII.4 
60 Viral suspension 
(FCV+NoV GII.4) 
 
15 0.6 RT-PCR (32) 
NoV 
GII.4 
80 Viral suspension 
(FCV+NoV GII.4) 
0.9 RT-PCR 
NoV 
GII.4 
60 Viral suspension 
(FCV+NoV GII.4) 
in spiked mussels 
0.3 RT-PCR 
NoV 
GII.4 
80 Viral suspension 
(FCV+NoV GII.4) 
in spiked mussels 
0.5 RT-PCR 
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Table 1.8 Heat inactivation parameters of MNV in different matrices at different temperatures. 
Temp (°C) Matrix Vessel Time  D-value (min) Log Reduction Unit Reference 
50 Cell culture Glass capillary tube   34.49     (18) 
56   3.65     
60   0.57     
65   0.3     
72   0.15     
63 Water 0.2 ml PCR tube 10 min 0.9 3.28 PFU/ml (57) 
72 <0.3 >3.5 
63 Milk 0.7 >3.5 
72 0.5 >3.5 
50 Cell culture 0.2 ml PCR tube 2 min   0.81 PFU/ml (59) 
55   1.69 
60   3.11 
65 Raspberry (pH 
3.1) 
Stomacher bag 30s   1.86 PFU/g (11) 
75 15s   2.81 
50 Blue mussels 2ml glass vials 6 min 20.19 2.11 PFU/ml (23) 
56 
  
3 min 6.12 1.76 
  
60 
  
60 s 2.64 2.15 
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Table 1.8 Continued 
 
Temp (°C) Matrix Vessel Time  D-value (min) Log Reduction Unit Reference 
50 Spinach 2ml glass vials 6 min 14.57 0.47 PFU/ml (17) 
56 3 min 3.29 1.82 
60 3 min 0.98 3.61 
65 40 s 0.4 3.66 
72 20 s 0.16 3.21 
56 Cell culture microcentrifuge tube 20 min   >5 TCID50/ml (33) 
10 min   5.5 
50 Cell culture 2ml glass vials   36.28   (19) 
56   3.74   
60   1.09   
65   0.77   
72   0.25   
50 Turkey deli meat Vacuum bag   21   (21) 
56   7.3   
60   2.7   
65   0.9   
72   0.2   
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Table 1.9 Heat inactivation parameters of FCV in different matrices at different temperatures. 
Temp 
(°C) 
Matrix Vessel Time D-value 
(min) 
Log 
Reduction 
Unit Reference 
50 Cell culture Glass capillary tube   20.23     (18) 
56   6.36     
60   0.56     
65   0.32     
72   0.11     
50 Blue mussels 2ml glass vials 6 min 5.2 1.81 PFU/ml (23) 
56 3 min 3.33 2.75 
60 60 s 0.77 4.93 
65 15 s 0.33 5.62 
72 10 s 0.07 6.41 
50 Spinach 2ml glass vials 6 min 17.39 0.68 PFU/ml (17) 
56 3 min 5.83 2 
60 3 min 0.78 4.64 
65 40 s 0.27 5.76 
72 20 s 0.15 3.17 
56 Cell culture microcentrifuge tube 20 min   >5 TCID50/ml (33) 
10 min   4.5 
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Table 1.9 Continued 
Temp 
(°C) 
Matrix Vessel Time D-value 
(min) 
Log 
Reduction 
Unit Reference 
60 Viral suspension (FCV+NoV GII.4) 
 
15 min   0.4 RT-PCR (32) 
Cell culture   >3.5 TCID50/ml 
80 Viral suspension (FCV+NoV GII.4)   0.6 RT-PCR 
Cell culture   >3.5 TCID50/ml 
60 Viral suspension (FCV+NoV GII.4)   0.8 RT-PCR 
Spiked mussels   2.2 TCID50/ml 
80 Viral suspension (FCV+NoV GII.4)   1.2 RT-PCR 
Spiked mussels   2.2 TCID50/ml 
50 Cell culture 2ml glass vials   19.95   (19) 
56   6.37   
60   0.94   
65   0.72   
72   0.21   
50 Turkey deli meat Vacuum bag   9.9   (21) 
56   3   
60   0.8   
65   0.4   
72   0.1   
55 
 
Table 1.10 Heat inactivation parameters of HAV in different matrices at different temperatures. 
Temp (°C) Matrix Vessel Time (min) D-value (min) Log Reduction Unit Reference 
50 Mussels 2ml glass vials   54.17     (20) 
56   9.32     
60   3.25     
65   2.16     
72   1.07     
42.7 Green onions Dehydration for 
20h at target 
temp 
20 hours   0.84 PFU/ml (115) 
50.6   0.94 
56.4   1.61 
60.7   2.64 
65.9   3.91 
63 water 0.2 ml PCR tube 10 min 0.6 >3.5 IU/ml (58) 
72 <0.3 >3.5 
63 milk 1.1 >3.5 
72 <0.3 >3.5 
50 Spinach Vacuum bag   34.4     (24) 
56   8.43     
60   4.55     
65   2.3     
56 
 
Table 1.10 Continued 
Temp (°C) Matrix Vessel Time (min) D-value (min) Log Reduction Unit Reference 
56                   Cell culture 2ml glass vial   8.4  
 
(19) 
60 
  
  2.67  
  
65 
  
  1.73  
  
72 
  
  0.88  
  
50 Turkey deli meat Vacuum bag   42  
 
(21) 
56   20.6  
60   5.9  
65   2.3  
72   1  
57 
 
 
Table 1.11 Heat inactivation parameters of TV in different matrices at different temperatures. 
 
Temp 
(°C) 
Matrix Vessel Time 
(min) 
D-value 
(min) 
Log 
Reduction 
Unit Reference 
50 Cell 
culture 
0.2 ml PCR 
tube 
2 min   1.79 PFU/ml (59) 
55   1.83 
60   2.9 
65   3.07 
56 Cell 
culture 
microcentrifuge 
tube 
20 min   ~3.5 TCID50/ml (33) 
10 min   ~4 
56 Cell 
culture 
microcentrifuge 
tubes 
  11.8     (123) 
63   2.6     
72   4.3     
37 Cell 
culture 
microcentrifuge 
tubes 
  500     (7) 
56   4.03     
63   1.18     
72   0.24     
58 
 
Table 1.12 Heat inactivation parameters of AiV in different matrices at different 
temperatures. 
 
Temp 
(°C) 
Matrix Vessel Time 
(min) 
Log 
Reduction 
Unit Reference 
56 Cell 
culture 
microcentrifuge 
tube 
20 min 4 TCID50/ml (33) 
10 min 5 
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CHAPTER II  
THERMAL INACTIVATION KINETICS OF TULANE VIRUS IN MEDIA 
AND SPINACH 
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1 ABSTRACT 
Human noroviruses (HNoVs) cause gastrointestinal diseases worldwide. Tulane virus 
(TV) is recognized as a cultivable HNoV surrogate used to determine control measures 
against HNoVs. The objective of this study was to determine the heat inactivation 
kinetics (D- and z-values) of TV in cell-culture media in 2ml glass vials and spinach in 
vacuum bags using the first-order and Weibull models. TV in cell-culture media at ~7 
log PFU/ml in 2-ml glass vials was heated at 52, 54, 56 and 60oC for up to 10 min in a 
circulating water-bath. Survivors were enumerated by plaque assay using confluent 
LLC-MK2 cells in 6-well plates. Each treatment was replicated thrice, assayed in 
duplicate and data were statistically analyzed. The D-values by the first order model 
for TV in cell culture media at 52, 54, 56 and 60oC were 4.59±0.02, 
2.91±0.01, 1.74±0.41 and 0.58±0.36 min, respectively, with a z-value of 9.09±0.01oC 
(R2 = 0.997). The Weibull model showed td=1 values of 2.53±0.08, 1.99±0.10, 
0.57±0.64 and 0.22±0.25 min, respectively for TV at the same temperatures. The D-
values for TV in spinach were 7.94±0.21, 4.09±0.04 and 1.43±0.02 min and a z-value 
of 10.74±0.01oC (R2 = 0.98) by the first order model and 4.89±0.02, 3.21±0.45 and 
0.25±0.38 min for the Weibull model at 50, 54 and 58oC, respectively. In comparison 
to MNV-1, TV in cell-culture media and spinach showed lower D- and z-values. TV 
may not be as suitable a surrogate as MNV-1 for HNoV heat inactivation studies in 
cell culture media in 2-ml vials or spinach in vacuum bags.  
62 
 
2 INTRODUCTION 
Human noroviruses (HNoVs) are the leading causative agents of acute gastroenteritis 
responsible for illness of 1 in every 15 people each year in the United States alone 
(22). Fever, diarrhea, vomiting, chills, and severe dehydration are some of the 
common symptoms of HNoV infection (21). Human noroviruses pose a potential risk 
to public health as it has a low infectious dose and can spread through water, food, 
and person-to-person contact (17).  Consumption of HNoV-contaminated minimally 
processed food and fresh produce, shellfish, ready- to-eat meals, sandwiches, baked 
products, water, and ice pose health risks to humans (20, 26). Human noroviruses 
belong to the Caliciviridae family and contain a single-stranded positive-sense RNA of 
7.5 to 8.5 kilobases in length enclosed in a capsid (14). Currently there are six known 
genogroups of HNoVs (with one additional genogroup proposed) out of which 
genogroup I (GI), GII, and GIV affect humans (15). Due to the difficulty in assessing 
infectivity and current unavailability of animal models or cell culture infectivity assays 
for HNoVs, animal caliciviruses such as murine norovirus (MNV-1), feline calicivirus 
(FCV-F9), porcine enteric sapovirus (PEC), and Tulane virus (TV) are used as 
surrogates for current research (12, 13, 17).  
Tulane virus was recently isolated from the stool samples of rhesus monkeys 
that belongs to the genus Recovirus in the Caliciviridae family (25). Similar to HNoVs, 
it binds to histo-blood group antigens and is closely related to HNoV genogroup II (17). 
It is small, non-enveloped, and icosahedral with positive-sense, single-stranded RNA 
genome which is 6714 nt in length and 40 nM in diameter (14). Both, HNoV and TV 
have three open reading frames (ORF) wherein ORF1 encodes non-structural protein, 
ORF2 encodes the capsid protein (VP1), and ORF3 encodes minor structural proteins 
(VP2) (14). The 90 dimers of capsid protein are divided into two domains, the shell 
domain (S) which is an eight-folded jellyroll structure and forms the icosahedral shell 
and the protruding domain (P) with subdomains P1 and P2, which emanate from S 
and form the dimeric protrusion and is responsible for the viral entry into the host cell 
(27). The VP1 (capsid protein) comprises of 534 amino acids (aa) with a molecular 
mass of 57.9 kilodaltons (kDa), whereas VP2 (minor structural protein) contains 218 
aa and has a molecular mass of 22.8 kDa (14). Hence, this cultivable virus is used to 
determine appropriate inactivation methods against HNoV. 
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When comparing HNoV surrogates for their stability under different 
environmental conditions, TV and MNV-1 in cell culture media were reported to be 
more pH resistant than FCV-F9. Both, TV and MNV-1 showed <0.5 log PFU/ml 
reduction in infectivity with 100 mM citric acid (pH 2) and only ~ 2 log PFU/ml reduction 
with 100mM carbonate buffer (pH 10) after 30 min at 37°C, while FCV-F9 titers are 
reduced to non-detectable levels at both pH 2 and pH 10 under the same conditions 
(12). TV showed reduction in infectivity of 1.2 log PFU/ml when treated with 
commercial bleach (1,000 ppm chlorine) for 5 min at room temperature on stainless 
steel discs, while MNV-1 showed a slightly higher reduction of 1.4 log PFU/ml (11). 
FCV-F9 was the most sensitive among the three tested viruses that showed 5.3 log 
PFU/ml reduction under the same treatment conditions (12). TV is also known to be 
highly resistant to high hydrostatic pressure processing showing 6 log PFU/ml 
reduction at 600 MPa for 1 min at 4°C, as compared to 300 and 400 MPa pressure 
required for FCV-F9 and MNV-1, respectively (12). These results suggest that TV is 
most resistant to change in pH, pressure or chlorine concentration as compared to 
FCV-F9 and MNV-1 under the given conditions, and is therefore a suitable surrogate 
for HNoV for the above-mentioned processing and inactivation approaches. 
Thermal inactivation has been used traditionally and most-widely to inactivate 
pathogens in food and thus preserve the food. Heat disrupts the hydrogen bonding of 
proteins and destroys the spatial relationships necessary to maintain the structural 
integrity of bacterial and viral proteins thereby leading to their denaturation as well as 
the destruction of virus particles into non-infectious viral subunits and single proteins 
(8, 23). Above 60°C, after the inactivation of host-cell recognition and binding 
receptors, an alteration of the tertiary protein structure is reported to occur, which can 
facilitate the access of thermal energy to the nucleic material (3). For industrial 
purposes and to understand the heat inactivation kinetics of microorganisms, D- and 
z-values are determined. The D-value is defined as the time at a given temperature 
necessary to reduce a microbial population present in a defined medium by 90% (or 
one-log) and is indicative of the thermal resistance of a microorganism at a constant 
temperature (4, 6). The z-value is the change in temperature required to increase or 
decrease the D-value by 90% and is indicative of the temperature dependence of 
microbial inactivation (4, 6). Inversing the slope of log D versus temperature is used 
to obtain the z-value. Earlier research has been carried out on cultivable HNoV 
surrogates, FCV-F9, MNV-1 as well as hepatitis A virus (HAV) in buffer and various 
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model food systems (6-8, 25). Although studies have been performed to analyze 
thermal inactivation kinetics of TV in media, only 1.5 ml centrifuge tubes (2, 24) or 0.2 
ml PCR tubes (17) or capillary tubes (1) were used. The heat-inactivation kinetics of 
TV in 2-ml glass vials as well as the Z- values have not been reported to date. The 
container type and size can play a role in heat-inactivation due to differences 
associated with the heat transfer rate and come-up times (7). Moreover, the heat-
inactivation or persistence of HAV, MNV-1 and FCV-F9 have been previously reported 
in leafy vegetables including spinach (6, 8), lettuce (18), basil and parsley (11). To the 
best of our knowledge, there are no reported studies on thermal inactivation of TV in 
spinach. 
The objectives of this study were to (i) determine the D- and z-values of TV in 
cell-culture media contained in 2-ml glass vials, (ii) determine the thermal inactivation 
behavior of TV in spinach in vacuum bags, and (iii) compare the first order and Weibull 
models to describe the heat inactivation trends of TV in terms of selected statistical 
parameters. The suitability of using TV as a relevant surrogate for heat inactivation of 
HNoV would be thus determined. 
 
3 MATERIALS AND METHODS 
3.1  Virus and Host 
Tulane virus (TV) was obtained as a gift from Dr. J. Jiang (Cincinnati Children’s 
General Hospital, Cincinnati, Ohio) and LLCMK-2 host cells were used for virus 
infectivity and propagation. TV stocks were prepared by infecting confluent LLC-MK2 
cells in 175 cm2 flasks with Opti-MEM (minimum essential media; Opti-MEM® I 
Reduced Serum Medium, GlutaMAX™ Supplement, Grand Island, NY) containing 1 
X Anti-anti (Antibiotic Antimycotic; Invitrogen, Grand Island, NY), supplemented with 
2% heat inactivated fetal bovine serum (FBS; HyClone Laboratories, Logan, UT) and 
incubating at 37°C under 5% CO2 until lysis for 3 days as reported before (11, 16). 
The virus was recovered by centrifugation at 5000×g for 10 min, followed by filtration 
through 0.2 µm (2 × 10-7m) filters, aliquoted, and stored at -80°C until use. 
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3.2  Heat Treatment of TV with cell-culture media in 2-ml glass vials  
Heat treatment was carried out in a circulating water bath (Isotemp 2150, Fisher 
Scientific, Pittsburgh, PA) in 2-ml screw-capped glass vials as reported earlier (7). 
Briefly, autoclaved (121°C, 15 min) vials were carefully filled with 1.8 ml TV by using 
sterile micro pipettes in a biosafety cabinet. The vials containing TV were surface 
rinsed in 70% ethanol before immersion in a thermostatically controlled water-bath. 
The temperature was confirmed by placing one end of type-T thermocouple (Omega 
Engineering, Inc., Stamford, CT) in the geometric center of the water-bath and another 
thermocouple probe was placed at the geometric center of a vial through the lid to 
monitor the temperature of the buffered media as reported earlier (7). These 
thermocouples were connected to MMS3000-T6V4 type portable data recorder 
(Commtest Inc., New Zealand) to monitor temperature. The 2-ml glass vial containing 
samples were held at 52, 54, 56 and 60°C for varying treatment times of 0 to 10 min. 
The treatment time began (recorded as come-up time) when the target internal 
temperature reached the target temperature. The come-up times were 120, 140, 172 
and 163 s for 52, 54, 56 and 60°C. After the thermal treatment, sample vials were 
surface rinsed with 70% ethanol and immediately cooled in an ice water bath for 15 
min to stop further thermal inactivation. Un-heated virus suspensions in 2-ml glass 
vials were used as controls. Ten-fold serial dilutions of the virus were carried out in 1.5 
ml Opti-MEM (containing 2% FBS, and 1% antibiotic-antimycotic) and enumerated by 
plaque assays. 
 
3.3  Inoculation of spinach with TV 
Frozen chopped spinach samples from local grocery stores were mildly heated in the 
microwave (700 Watts/120 Volts/15 Amps) for 5 min and blended using a blender for 
homogenization. Five-milliliters of TV stock with initial titers of 7.25 ± 0.05 log PFU/ml 
was aseptically added to 25 g of spinach sample in a sterile beaker, covered with foil 
in a biosafety hood and stirred overnight under refrigeration at 4°C. 
 
3.4 Thermal treatment of spinach inoculated with Tulane virus 
Six-milliliter samples of homogenized TV-inoculated spinach were added to moisture 
barrier plastic bags (13 cm × 19 cm) and were vacuum sealed in to -100 kPa (Multivac 
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A300/16 vacuum packaging unit, Sepp Haggemuller KG, Wolfertschwenden, 
Germany), and were then flattened and placed in a holding unit as described before 
(10). Briefly, the holding unit was immersed in a thermostatically controlled circulating 
water bath (± 1°C) whose temperature was confirmed with by placing one type-T 
thermocouple (Omega Engineering, Inc., Stamford, CT) in the geometric center of the 
water-bath and another thermocouple probe at the geometric center of an 
uninoculated bag of spinach. As described above for the 2-ml vials, the thermocouples 
were connected to a MMS3000-T6V4 type portable data recorder (Commtest Inc., 
New Zealand) to monitor temperature. The spinach samples containing TV were held 
at 50, 54 and 58oC for varying treatment times of 0-8 min. The treatment time began 
(and was recorded as come-up time) when the target internal temperature reached 
the desired temperature. The come-up time for target temperature in vacuum bags 
were 44.5, 79.5 and 168.7 s for 50, 54 and 58°C respectively. The bags were rinsed 
with ethanol and cooled in an ice bucket after the set-time at target temperature. Un-
heated virus suspensions from uninoculated spinach bags were used as controls. 
 
3.5 Tulane virus extraction from spinach 
Virus extraction was performed as described by Bozkurt et al. (7) with some 
modifications. In a biosafety cabinet, the spinach inoculated with TV bags were 
aseptically cut with sterilized scissors to transfer the contents to sterile beakers. For 
virus elution form the spinach, 15-ml elution buffer containing 0.1 M Tris-HCl, pH 9.5 
(to elute the virus particles from the spinach sample in the presence of an alkaline 
environment), 3% beef extract paste and 0.05 M glycine (to reduce non-specific virus 
adsorption to the food matrix during extraction) was used. After adjusting the pH to 9.5 
using 10 M NaOH, the samples were kept rotated on a shaking platform at 120 rpm 
for 20 min at 4°C. These samples were then transferred to sterile stomacher bags with 
filter compartments, and stomached twice at high speed for 40 s intervals. The 
obtained filtrate was centrifuged at 10,000×g for 15 min at 4°C, and the pH of the 
supernatant was adjusted to 7.2-7.4 using 6 N HCl to facilitate the polyethylene glycol 
precipitation of the virus particles as reported earlier (6). Polyethylene glycol 6000 
(PEG) (to precipitate virus at high ionic concentrations without precipitation of other 
organic materials) and NaCl was added to obtain a final concentration of 10% PEG 
and 0.3 M NaCl. These samples were placed on a shaking platform (120 rpm) 
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overnight at 4°C and then centrifuged at 10,000×g for 30 min at 4°C. After discarding 
the supernatant, the remaining pellet, containing the virus, was dissolved in 1 ml of 
phosphate-buffered saline. Virus extracts were stored at -80°C until enumeration of 
plaques using the TV plaque assay. 
 
3.6 Tulane Virus Plaque Assay 
TV survivors were enumerated by infecting 500 µl of aliquots of dilutions of heat-
treated or untreated virus on to confluent LLC-MK2 host cells in 6-well plates for 3 h 
at 37°C with 5% CO2 before overlaying with 2X media comprising of Opti-MEM 
(containing 2% FBS, and 1% antibiotic-antimycotic) in 1.5% Noble agar (Difco Agar 
Noble, BD, Sparks, MD). Plates were then incubated at 37°C for 3 days followed by 
staining with neutral red and 1:1 Opti-MEM (containing 2% FBS, and 1% antibiotic-
antimycotic) in 1.5% Noble agar and plaques were counted. Viral survivors or 
infectious particles were enumerated as plaque forming units/ml (PFU/ml).  
 
3.7 Statistical Analysis 
Each experiment at each temperature was repeated thrice and assayed in duplicate 
and data was analyzed using SAS 9.4 (SAS Institute, Cary, NC, USA) with PROCREG 
command for linear model and NLIN command for Weibull model. 
 
3.8 Modeling of inactivation kinetics 
First-order kinetics: The traditional approach to describe the change in number of 
survivors over time for first-order kinetic model can be written using the following 
equation (as described earlier (4, 6): 
-
dN
dt
 = kN 
                                          
N(t)
N0(t)
 = e-kt                                             (6) 
This is an equation of a straight line with a slope –k, where N(t) is the number of 
survivors after an exposure time (t) in PFU/ml and the initial population is N0 (PFU/ml). 
D-value is the decimal reduction time in min (time required to inactivate 90% of viruses 
at a given temperature) and t is the treatment time (min).  
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Z-value is defined as the change in temperature necessary to cause a 90% change in 
the decimal reduction time (D-value) (4, 6). The D-values for different temperatures 
were plotted on semilog coordinates, and the temperature increase for a one log-cycle 
change in D- values was calculated as the z- value. Based on the definition, z- value 
has been expressed by the following equation: 
Z = 
T2-T1
logD2-logD1
 
Weibull Model: 
log (
𝑁
𝑁0
)  =  −𝑏 ∗ (𝑡𝛽) 
𝑏 = (
1
2.303
) ∗ (𝛼−𝛽) 
From this we get value of alpha after substituting values of b and β. 
Td  =  α*(- ln(10
-d))
1/β
 
Where d is the targeted decimal reduction. 
After iteration of b and β for best fit, we get value of Td=1, for that data set. 
Here α and β are scale and shape parameters, respectively. β< 1 implies that the 
surviving particles are infectious, whereas β> 1 implies that particles are damaged and 
are non-infectious (7, 16). The Weibull distribution corresponds to a concave upward 
(tailing) survival curve if β is <1, concave downward (shoulder) if β is >1, and linear 
if β equals 1 (19). Concave upward or tailing behavior indicates that some population 
can survive the applied heat, while sensitive members of the population are destroyed 
relatively quickly, whereas a concave downward behavior shows that the population 
is increasingly damaged (6). 
 
4 RESULTS AND DISCUSSION 
TV at an initial titer of 7.22±0.18 log PFU/ml (±standard error) was used for heat 
inactivation, where significant differences in the number of survivors at 52, 54, 56 and 
60°C at all tested time points were obtained (P<0.05). Figure 2.1 shows the average 
recovered titer of TV at the different time points for each inactivation temperature. 
Unheated TV at room temperature (22°C) was used as positive control. At 52°C, the 
average TV titer decreased from 6.37±0.41 log PFU/ml at 0 min to 3.84±0.35 log 
PFU/ml after 10 min. Similarly, at 54°C, the average titer of TV decreased from 
6.38±0.21 log PFU/ml at 0 min to 3.02±0.14 log PFU/ml after 10min. Similarly, at 56°C, 
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the average number of viral survivors decreased from 6.08±0.3 log PFU/ml to 
undetectable after 10 min, and at 60°C it decreased from 4.49±0.06 log PFU/ml to 
undetectable level after 1.5 min, respectively, with limit of detection as 1 log PFU/ml. 
While there was a decrease of about only 3 log PFU/ml in TV titers after heating at 
52°C for 10 min, an increase in temperature resulted in TV titer reduction to non-
detectable levels by plaque assay after 10 and 1.5 min at 56 and 60°C, respectively 
(Figure 2.1). This shows that both increasing time and temperature have a direct 
relationship to TV titer reduction. The D-values for TV in 2-ml glass vials at 52, 54, 56 
and 60°C calculated from first order model were 4.59 ± 0.05, 2.91 ± 0.05, 1.74 ± 0.07 
and 0.58 ± 0.02 min, respectively with z- value as 9.09°C (R2 = 0.997) (Figure 2.2B). 
Previously in literature, a D-value of 1.09 min at 55°C for TV has been reported 
by Hirneisen and Kniel using 0.2 ml PCR tubes (17). However, Tian et al. (23) and 
Arthur and Gibson (2) reported higher D-values at 56°C of 11.8 and 4.03 min, 
respectively while at 63°C D- values were 2.6 and 1.18 min, respectively in 1.5 ml 
microcentrifuge tubes using the first order model (2, 24). These results were similar to 
the results reported by Araud et al. (1) who showed a D-value of 2.38 min at 62°C in 
cell culture media in capillary tube with first order model (1, 2, 24). However, in this 
current study, a D-value of 0.58 min at 60°C in 2-ml glass vials was obtained. The 
difference in the D-values obtained could be due to the difference in the type of 
container and heat-transfer rate. Microcentrifuge tubes or 0.2 ml thin walled PCR 
tubes, made from polypropylene, can reach the desired temperature almost instantly 
when heated in a thermocycler, while there was a short come-up time required to 
achieve the desired temperature in the case of the glass 2-ml vials in a circulating 
water bath (8). The come-up times were 120, 140, 172 and 163 s for 52, 54, 56 and 
60°C. During the come-up time, which was indicated by the 0 min time point, the 
reduction in number of survivors varied from 0.41 to 3.05 log PFU/ml from 52 to 60°C, 
respectively, and hence can lead to differences in the D-values when compared to that 
obtained by using polypropylene microcentrifuge tubes. Thus, the type and shape of 
the container played an important role in determining the heat inactivation kinetics of 
these viruses as also reported earlier (5). The difference in the methods of detection 
such as tissue culture infectious dosage (24) or plaque assay can also contribute 
towards difference in D-values. 
 The shape and scale parameters for the Weibull model for the different 
temperatures were used to calculate Td = 1 value as an analogue to D-value from first 
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order model (Table 2.1). The results revealed that the value of scale parameter, α 
ranged from 0.64 to 0.06 min when temperature increases from 52 to 60°C. This 
shows that as temperature increases and value of α decreases, there is a faster 
reduction in the number of survivors over a shorter duration of time. In comparison, 
MNV-1 and FCV-F9 also showed a reduction in α with an increase in temperature. For 
MNV-1, α decreased from 7.42 to 0.14 min from 50 to 72°C, while for FCV-F9 it 
decreased from 5.17 to 0.14 min from 50 to 72°C (6). The values obtained for β show 
a tailing behavior (concave upward) (Table 2.1). These findings are similar to Bozkurt 
et al. (6) which show that both MNV-1 and FCV-F9 had tailing and shoulder behavior 
which was irrespective of the heating temperature. 
 As a change in the scale factor described a change in the heating environment, 
as opposed to a nearly constant shape factor, a second order polynomial was derived 
to measure the influence of temperature on scale factor and hence, Td = 1 values: 
α =  0.005[T(°C)^2] –  0.61 T(°C)  +  19.66     R2 = 0.80 
On using an average β value of 0.65, the dependence of Td = 1 on scale 
parameter can be expressed as: 
Td = 1 =  1.72α 
Td = 1 values obtained from the Weibull model were 2.53 ± 0.08, 1.99 ± 0.1, 0.57± 
0.41 and 0.22 ± 0.25 min for the same temperatures, respectively with z- value as 
7.14°C (R2 = 0.95) (Figures 2.2B). This indicates over-processing for one log reduction 
in case of first order model as compared to Weibull model. Moreover, as one log 
reduction is rarely used in industry, time required to achieve 6 log reduction was 
calculated, which is represented by 6D and Td=6 for first order and Weibull model, 
respectively as described before by Bozkurt et al. (5, 6, 7) (Table 2.3). The results 
indicate that for the studied temperature range (52-60°C), under-processing may 
occur for a targeted six log reduction when first order model is applied, instead of 
Weibull model. Similar observation has been reported for FCV-F9, MNV-1 and HAV 
with 6D values of 38.22, 22.44 and 50.4 min and Td=6 values of 43.73, 29.66 and 58.57 
min, respectively at 56°C, showing under processing in case of first order model as 
compared Weibull model (9). TV had a much lower Td=1 value at 60°C of 0.22 min as 
compared to MNV-1 or FCV-F9 in 2-ml vials in cell culture media, which had Td=1 
values at 56°C of 1.11 min and 0.91 min, respectively (6). 
The D-value of TV at 56°C (1.74±0.07 and 0.57±0.41 min, using first order and 
Weibull model, respectively and a z-value of 9.09°C), is lower than that of various 
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cultivable HNoV surrogates reported in literature. MNV-1 in cell-culture media had a 
D-value of 3.74 ± 0.68 and 2.34±0.43 min at 56°C in 2-ml glass vials and a z-value of 
9.31 and 9.19°C using first order and Weibull model respectively (5). On the other 
hand, FCV-F9 had a D-value at 56°C of 6.37±0.59 and 4.05±0.09 min, and a z-value 
of 9.36°C and 9.31°C using first order and Weibull model, respectively (6). For HAV, 
the D-value at 56°C was 8.4±0.43 and 11.11±8.73 min and the z-value was 12.49°C 
and 14.05°C, using first order and Weibull model respectively (6, 7). At 56°C, HAV 
appears to be the most resistant to heat followed by FCV-F9, MNV-1 and TV. HNoV 
GII.4 had a reported D-value of 100 min at 56°C and z-value of 20.61°C in 1.5 ml 
microcentrifuge tubes as measured by in situ capture quantitative reverse transcription 
PCR (25). Therefore, it appears that at 56°C HNoV could be most resistant as 
compared to any of its surrogates and HAV. However, this data should be interpreted 
with caution because infectious assays were not used during this study due to 
unavailability of cell-culture systems for infectious HNoVs at that time. 
TV titers from unheated spinach (control) ranged from 6.95 ± 0.13 to 5.28 ± 
0.10 log PFU/ml, indicating a recovery of 73 to 96% which was similar to that observed 
by Bozkurt et al. (5) showing 97 and 89% recovery for MNV-1 and FCV-F9 in spinach. 
This suggests that there is greater adsorption of foodborne viruses on the food 
matrices that can lead to outbreaks when consumed raw or under-cooked. The come-
up time for target temperature in vacuum bags were 44.5, 79.5 and 168.7 s for 50, 54 
and 58°C respectively. In the current study, the first order model D-value of TV in 
spinach in vacuum bags at 50°C was 7.94 min, which is lower than the D-value of 
14.57 and 17.39 min for MNV-1 and FCV-F9, respectively in 2-ml glass vials and 34.4 
min for HAV in vacuum bags at 50°C. The z-value calculated for TV in spinach was 
10.74°C (R2 = 0.98) using the first order model as shown in Figure 2.3. Lower D-values 
of TV in cell culture matrix in 2-ml glass vials compared to D-values in spinach in 
vacuum bags were observed such as 2.91±0.05 and 4.09±0.04 min, respectively at 
54°C using first order model. Similar trends have been reported previously in literature 
for HAV at temperatures above 56°C showing lower D-values in cell culture media in 
2-ml glass vials (2.67±0.42 min at 60°C) as compared to D-values in spinach in 
vacuum bags (4.55±0.82 min at 60°C) (10). 
As β ranges from 0.17, 0.78 and 0.43 at 50, 54 and 58°C, the Weibull model 
shows that the heating temperature did not influence the shape parameter, whereas 
α decreased from 2.24, 1.09 and 0.04 min (Table 2.2). Td=1 value for TV in spinach in 
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vacuum bags (4.89 min at 50°C) was lower than those reported for MNV-1, FCV-F9 
of 15.26 and 20.71 min, respectively in spinach using 2-ml glass vials at 50°C (5). The 
calculated 6D values at 50°C were 206.4 and 47.64 min for HAV and TV in spinach in 
vacuum bags and 104.34 and 87.42 min for MNV-1 and FCV-F9 in spinach in 2 ml 
glass vials (5, 10). 
On analysis of heat treatment on the capsid integrity of TV, it was reported that 
at 80°C after the shortest time point of 5 s, the appearance of the heated virus changed 
with the loss of normal round structure which was accompanied with appearance of 
rough edges (1). It is known that the protruding domain of the capsid protein is 
responsible for viral entry into the host cell (27), therefore, the loss of capsid integrity 
can lead to reduction in host cell binding. The decrease in infection ability due to loss 
of capsid integrity could explain the greater reduction of TV at high temperature of 
60°C. Further, unfolding of capsid protein and loss of capsid integrity could lead to 
nucleic acid degradation and therefore loss of infectivity (2). 
In summary, based on the regression co-efficient that was comparatively higher 
for the Weibull model than the first order model, the Weibull model seems to better 
represent the heat-inactivation behavior of TV. When comparing the heat-inactivation 
behavior of HNoV surrogates, it appears that overall MNV-1 (except at 56oC) is more 
heat-resistant than FCV-F9 or TV. However, HAV is more heat-resistant than all the 
currently known cultivable HNoV surrogates. Thus, based on the data from this study 
with TV in 2-ml vials and inoculated spinach in vacuum bags, TV does not appear to 
be as suitable as MNV-1 as a HNoV surrogate for use in heat-inactivation studies. 
Based on these results and that an ideal surrogate should be more resistant to 
treatments than the target pathogens, be non-pathogenic, easily cultivable in the 
laboratory and industrial settings, and easy to handle, further studies are on-going and 
needed to determine a suitable cultivable HNoV surrogate for future validation studies.  
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7 APPENDIX 
Figures 
 
 
Figure 2.1. Thermal treatment of Tulane virus (TV) in cell culture media after 
heating for various times at different temperatures of 52, 54, 56 and 60°C in 2-ml 
glass vials using first order model.  
 
Error bars represent the standard errors (SE) from the three replicates of plaque 
assays carried out in duplicate for evaluating inactivation of the virus. 
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Figure 2.2. Comparison of thermal inactivation curves of Tulane virus (TV) in cell 
culture media in 2-ml glass vials using the first order and Weibull models. The 
data points represent Log10 D (A) or Td=1(B) (min) values for three replicates at 
52, 54, 56 and 60°C used for computing Z-values for (A) first order model (R2 = 
0.997) and (B) Weibull model (R2 = 0.95).  
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Figure 2.3. Thermal inactivation curves of Tulane virus (TV) in spinach in 
vacuum bags for (A) first order model (R2 = 0.98) and (B) Weibull model (R2 = 
0.86). 
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Tables 
 
Table 2.1. Coefficients of the first-order and Weibull models for the survival 
curves of Tulane virus (TV) during thermal inactivation in cell culture media 
using 2-ml vials.  
 
 Weibull distribution  First order kinetics 
T (°C) α(min) Td=1(min) β R2  D (min) R2 Z (°C) 
52 0.64±0.06 2.53±0.08 0.61±0.06 0.96  4.59±0.05 0.84 
9.09 
 
54 0.68±0.05 1.99±0.10 0.78±0.09 0.97  2.91±0.05 0.90 
56 0.15±0.09 0.57±0.41 0.64±0.03 0.98  1.74±0.07 0.92 
60 0.06±0.09 0.22±0.25 0.61±0.05 0.97  0.58±0.02 0.85 
 
*Thermal death time (Td = 1, D- values ± SE), shape and scale factors (β and α, 
respectively) and coefficient of determination (R2). The data is the average of three 
replicates assayed in duplicate for each temperature.  
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Table 2.2. Coefficients of the first-order and Weibull models for the survival 
curves of Tulane virus (TV) during thermal inactivation in spinach using vacuum 
bags.  
 
 Weibull distribution  First order kinetics 
T (°C) α (min) Td=1 (min) β R2  D (min) R2 Z (°C) 
50 2.24±0.06 4.89±0.02 0.17±0.04 0.99  7.94±0.21 0.60 
10.74 54 1.09±0.15 3.11±0.45 0.78±0.21 0.83  4.09±0.04 0.60 
58 0.04±0.02 0.25±0.38 0.43±0.10 0.96  1.43±0.02 0.81 
 
*Thermal death time (Td = 1, D- values ± SE), shape and scale factors (β and α, 
respectively) and coefficient of determination (R2). The data is the average of three 
replicates assayed in duplicate for each temperature.  
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Table 2.3. Calculated process time (min) to achieve 6-log reduction by the first-
order and Weibull models of Tulane virus (TV) during thermal inactivation in cell 
culture media in 2-ml glass vials and in spinach in vacuum bags.  
  
 
Model 
 
Temperature (°C) 
52 54 56 60 
Cell-culture                                        Time (min) 
First order (6D) 27.55 17.28 10.44 3.48 
Weibull (Td=6) 48.94 20.06 9.46 3.98 
Spinach 50 54 58  
First order (6D) 47.64 24.54 8.58  
Weibull (Td=6) 55.87 32.05 15.94  
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CHAPTER III  
THERMAL INACTIVATION KINETICS OF AICHI VIRUS IN 
CELL-CULTURE MEDIA USING 2-ML GLASS VIALS 
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1 ABSTRACT 
Aichi virus (AiV) is an emerging, non-enveloped, single-stranded RNA virus that 
causes human gastrointestinal disease associated with the consumption of 
contaminated water and shellfish. The current unavailability of vaccines and resistance 
of AiV to commonly-used inactivation techniques, makes it necessary to evaluate its 
thermal inactivation kinetics. The objective of this study was to determine the heat 
inactivation kinetics (D- and z-values) of AiV in cell-culture media using 2-ml glass 
vials by the first-order and Weibull models. AiV in cell-culture media at ~7.4 log plaque 
forming units (PFU)/ml in 2-ml glass vials was heated at 50, 54, 58°C for up to 90 min 
in a circulating water-bath. Survivors (infectious particles) were enumerated by plaque 
assay using confluent Vero host cells in 6-well plates. Each treatment was replicated 
thrice, assayed in duplicate and data were statistically analyzed. D-values for AiV in 
2-ml glass vials at 50±1°C (±=standard error) (come-up time=68s), 54±0.7°C (130s), 
and 58±0.6°C (251s) by the first order model were 47.62±1.2(R2=0.94, RMSE=0.19), 
7.14±1.13(R2=0.70, RMSE=0.34) and 2.12±0.04min (R2=0.70, RMSE=0.31), 
respectively, with a z-value of 5.92°C (R2=0.98, RMSE=0.25). The Weibull model 
showed Td=1 of 34.53±0.03 (R2=0.99, RMSE=0.16, α (scale parameter) =10.27, β 
(shape parameter) =0.69), 2.59±0.05 (R2=0.96, RMSE=0.23, α=0.22, β=2.59) and 
0.91±0.06 min (R2=0.96, RMSE=0.25, α=0.14, β=0.91) for the same temperatures, 
respectively with a z-value of 5.26°C (R2=0.94, RMSE=0.11). The Weibull model 
showed a better fit with higher R2 and lower RMSE values. These data should help in 
the industrial design of thermal processes to inactivate AiV and prevent AiV 
transmission and outbreaks. 
  
85 
 
2 INTRODUCTION 
The emerging foodborne enteric Aichi virus (AiV) was first isolated from stool 
specimens of patients suffering from acute gastroenteritis due to the consumption of 
contaminated raw oysters (29). This virus has a morphologically distinct round-
structure, ~ 20 to 40 nM in diameter and belongs to the genus Kobuvirus in same 
Picornaviridae family as Hepatitis A virus (HAV), which has three known species A, B, 
and C (27, 29). The viral genome consists of a single-stranded, positive-sense RNA 
molecule of 8,280 nucleotides and a poly(A) tail (1, 27). 
AiV is transmitted through the fecal oral route and has been known to spread 
through contaminated water and shellfish (17, 20, 27). It has thus far been reported to 
be isolated from stool samples over the world including Japan, France, Pakistan, 
Netherlands, Tunisia, Spain and South America (17, 19, 21, 22, 24, 27, 28). Symptoms 
of AiV infection include nausea, vomiting and diarrhea that can occur within 12 to 48 
h after ingestion, while fecal shedding of AiV can last for up to 5-7 days after infection 
(9, 24). Currently there are no available antivirals described for AiV infection treatment 
and its infectious dose remains unknown (4). 
 There have been few studies on the persistence and survival of AiV in different 
environments. AiV has shown to be stable in 10% chloroform for 3 h (27) and can 
survive without any significant reduction after high hydrostatic pressure processing 
treatment at 600 MPa for 5 min (15). However, AiV was reduced by 5 log TCID50/ml 
upon exposure to UV at 16 mW/s2 (14). AiV was reported to be more resistant than 
porcine enteric virus (PEC) and human norovirus (HNoV) surrogates such as murine 
norovirus (MNV-1), feline calicivirus (FCV-F9), and Tulane virus (TV) to inactivation 
treatments like pH, high hydrostatic pressure, heat and ethanol (10). Furthermore, 
recently our lab showed that AiV (at initial titer 5 log PFU/ml) had no significant 
reduction with aqueous hibiscus extracts at 100 mg/ml or 40 mg/ml at 37°C after 6 h, 
but was reduced to non-detectable levels after 24 h by both concentrations (11). 
 One of the most widely used techniques for the inactivation of foodborne 
pathogens is thermal inactivation. Heat has been known to alter the structural integrity 
of microorganisms by disrupting hydrogen bonding, denaturing the viral proteins and 
causing them to become non-infectious subunits (7, 23). Above 60°C, after the 
inactivation of host-cell recognition and binding receptors can occur, an alteration of 
the tertiary protein structure is reported to occur (3, 7). This is turn facilitates the access 
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of thermal energy to the nucleic material, causing its degradation as well as exposes 
the nucleic acid material to environment damage, enzymes such as nucleases, 
extreme pH, etc (3). For industrial purposes and to understand the heat inactivation 
kinetics of microorganisms, D- and z-values are determined. As previously described, 
the D-value is defined as the time at a given temperature necessary to reduce a 
microbial population present in a set medium by 90% and is indicative of the thermal 
resistance of a microorganism at a constant temperature (7). The z-value is the 
change in temperature required to increase or decrease the D-value by 90% and is 
indicative of the temperature dependence of microbial inactivation (7). Inversing the 
slope of log D versus temperature is used to obtain the z-value. 
 Given the high prevalence of AiV around the globe and its high resistance to 
many treatment and disinfection techniques, it becomes necessary to evaluate thermal 
inactivation kinetics of AiV to prevent its transmission and disease outbreaks. Hence, 
the objectives of this study were to (i) Determine the thermal inactivation kinetics of 
AiV in cell culture media using 2-ml glass vials and (ii) Compare the first order and 
Weibull models to describe the heat inactivation of AiV in cell culture media. The data 
obtained would be useful in designing appropriate heat inactivation parameters to 
prevent AiV transmission.  
 
3 MATERIALS AND METHODS 
3.1 Virus and Host 
AiV was obtained as a gift from Dr. David Kingsley (USDA ARS, Delaware) along with 
its host cell line, Vero cells. For preparation of virus stocks, AiV was propagated in 175 
cm2 flasks containing confluent Vero cells in Dulbecco’s Modified Eagle’s 
Medium/Ham’s F-12 (DMEM-F12; HyClone Laboratories, Logan, UT) containing 1 X 
Anti-anti (Antibiotic Antimycotic; Invitrogen, Grand Island, NY), supplemented with 2% 
heat inactivated fetal bovine serum (FBS) (Fetal Bovine Serum HyClone Laboratories, 
Logan, UT) and incubated at 37°C under 5% CO2 until lysis for 3 days as reported 
earlier (11, 14). The virus was recovered after freeze-thawing thrice, followed by 
centrifugation at 5000×g for 10 min, and filtering through 0.2 µm filters. The obtained 
filtrate was aliquoted and stored at -80°C until use. 
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3.2 Heat Treatment of AiV in cell-culture media contained in 2-ml 
glass vials 
Heat treatment was carried out in a circulating water bath (Isotemp 2150, Fisher 
Scientific, Pittsburgh, PA) in 2-ml screw-capped glass vials as reported earlier (7). 
Briefly, autoclaved (121°C, 15 min) vials were carefully filled with 1.8 ml AiV stock at 
7.41± 0.25 (± standard error) log PFU/ml initial titer, by using sterile micro pipettes in 
a biosafety cabinet. The filled vials were surface rinsed in 70% ethanol and immersed 
in a thermostatically controlled water-bath, whose temperature was monitored with 
thermocouples connected to MMS3000-T6V4 type portable data recorder (Commtest 
Inc., New Zealand). As previously reported, one end of the type-T thermocouple 
(Omega Engineering, Inc., Stamford, CT) was placed in the geometric center of the 
water-bath and another thermocouple probe end was placed in the geometric center 
of a vial through the lid to monitor the temperature of the buffered media (7). Samples 
were heated at 50, 54 and58°C for varying treatment times up to 10 min. The treatment 
time began (come-up time was recorded) when the target internal temperature 
reached the target temperature. The come-up times were 68, 130 and 251 s at 50, 54 
and 58°C, respectively. After the thermal treatment, sample vials were surface rinsed 
with 70% ethanol and immediately cooled in an ice water bath for 15 min to stop further 
thermal inactivation. Samples were aseptically serially diluted 10-fold first in DMEM-
F12 containing 10% FBS followed by subsequent 10-fold serial dilutions in 1.5 ml 
DMEM-F12 (containing 2% FBS) followed by enumeration of recovered infectious AiV 
using plaque assays. Un-heated virus suspensions were used as controls. 
 
3.3 AiV Plaque Assay 
AiV survivors were enumerated by infecting confluent Vero host in 6-well plates with 
500 µl of aliquots of dilutions of heat-treated or untreated virus cells and incubating at 
37°C with 5% CO2 for 3 h before overlaying with complete DMEM (containing 2% FBS, 
and 1% antibiotic-antimycotic) in 1.5% Noble agar (Difco Agar Noble, BD, Sparks, 
MD). Plates were then incubated at 37oC for 3 days followed by staining with neutral 
red contained in complete DMEM (containing 2% FBS, and 1% antibiotic-antimycotic) 
in 1.5% Noble agar and plaques were counted and reported as plaque forming units/ml 
(PFU/ml). Each experiment at each temperature was repeated thrice and assayed in 
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duplicate and data was analyzed using SAS 9.4 (SAS Institute, Cary, NC, USA) with 
PROCREG and NLIN commands for linear and Weibull models, respectively. 
 
3.4 Modeling of inactivation kinetics: 
First-order kinetics: The first order change in the number of survivors with time at a 
constant temperature, and as reported earlier, can be expressed as: 
-
dN
dt
 = kN 
                       
N(t)
N0(t)
 = e-kt                 (4) 
This is an equation of a straight line with a slope –k, where N(t) is the number of 
survivors after an exposure time (t) in PFU/ml and the initial population is N0 (PFU/ml). 
D is the decimal reduction time in min (time required to kill 90% of viruses) and t is the 
treatment time (min). The log-cycle change in D-values over temperature can be 
plotted on semi-log coordinates to obtain the z- value: 
Z = 
T2-T1
logD2-logD1
 
Where D2 and D1 are the different D-values at temperatures T2 and T1, respectively. 
 
Weibull Model: The Weibull model takes into consideration the scale and shape 
parameters which are α and β, respectively. The Weibull distribution corresponds to a 
concave upward survival curve if β is <1, concave downward if β is >1, and linear if β 
equals 1 (16). β<1 (concave upward or tailing behavior) implies that the surviving cells 
have retained the ability to be infectious, whereas β> 1 (concave downward) implies 
that the cells are damaged and are no longer infectious (7, 13). 
log (
𝑁
𝑁0
)  =  −𝑏 ∗ (𝑡𝛽) 
𝑏 = (
1
2.303
) ∗ (𝛼−𝛽) 
After iteration of b and β for best fit, we get value of Td=1, for that data set. 
From this we get value of alpha after substituting values of b and β. 
Td = 1 =  α*(- ln(10
-D))
1/β
 
Where D is the targeted decimal reduction (7). 
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4 RESULTS AND DISCUSSION 
AiV at an initial titer of 7.41± 0.25 (± standard error) log PFU/ml was used for 
heat inactivation, where significant difference between the number of survivors at 50, 
54, and 58°C at all tested time points were obtained (P<0.05). Unheated AiV at room 
temperature (22°C) was used as a positive control. AiV showed reduction of 0.46 and 
3.82 log PFU/ml after 10 min at 50 and 54°C, respectively. While at 58°C, AiV showed 
reductions of 4.19 to5.87 log PFU/ml after 0 and 3 min, respectively. This shows that 
both increasing time and temperature have a direct relationship in AiV titer reduction.  
The D-values for AiV in 2-ml glass vials at 50, 54, and 58°C calculated from first order 
model were 47.62± 1.12, 7.14±1.13 and 2.12±0.04 min, respectively (Table 3.1). The 
z-value calculated from first order model for AiV in 2-ml glass vials was 6.94°C (R2 = 
0.998) (Figure 3.1). 
In comparison to AiV, HAV was reported to have higher D-values of 56.22 min 
at 50°C, followed by 8.4, 2.67, 1.73 and 0.88 min at 56, 60, 65 and 72°C in cell culture 
media using similar 2-ml glass vials (7). It is known that the thermal stability of viruses 
depends on the ionic composition of media and this effect is different for different 
viruses. Although HAV and AiV have similarities as they belong to the same 
Picornoviridae family, such as being similar size (27-30 nm), non-enveloped 
icosahedral structure, positive single stranded RNA (7.5-8 kb length), they have 
differences in guanine+cytosine (G+C) content (59% for AiV and 38% for HAV). In 
addition, the amino acid (aa) sequence length and composition of the viral protein 1 
(VP1) (278 aa for AiV and 300 aa for HAV) might be another reason for the differences 
between the D-values of AiV and HAV (7, 29). HAV may have a more heat-stable 
capsid due to the protein structure arising from different amino acids and protein size. 
However, AiV with a D-value of 47.62 min in 2-ml glass vials at 50°C showed higher 
heat resistance than MNV-1 or FCV-F9 that had reported D-values of 36.28 and 19.95 
min at 50°C, respectively (7). TV has been previously reported to show D-values of 
500, 4.03, 1.18 and 0.24 min at 37, 56, 63 and 72°C in microcentrifuge tubes in cell 
culture media (2). MNV-1, FCV-F9, TV, SAV and AiV have similar non-enveloped 
icosahedral capsid, and a positive-sense single-stranded RNA (7.5-8 kb). Another 
reason for the differences in thermal resistance of these viruses could be attributed to 
the differences in isoelectric points (pH of 10 for TV (12), pH of 7.15 for HAV (26), pH 
of 4.1 for MNV-1 (18) and 4.27 for FCV-F9 (18) and 5 for porcine sapovirus (25)) that 
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may increase stability in the environment, associated with  its different amino acid 
sequence and length composition as reported for VP1 (530-550 aa for MNV-1, 668 aa 
for FCV-F9, 534 aa for TV) (12). 
In comparison to earlier heat inactivation reports, AiV has been found to show 
4 log PFU/ml reduction after 20 min at 56°C in microcentrifuge tubes (10). Differences 
in the D-values are attributed to the difference in type and shape of container 
composition, as polypropylene microcentrifuge tubes or PCR tubes, can reach the 
desired temperature almost instantly in a thermocycler, while in the case of the 2-ml 
glass vial, there is a short come-up time required to achieve the desired temperature 
in a circulating water bath (6). The come-up times for the 2-ml glass vials were 124, 
130 and 251s for 50, 54 and 58°C. The reduction in number of survivors during the 
come-up time is indicated by the 0 min time point. The reduction at 0 min varied from 
0.13 to 4.19 log PFU/ml from 50 to 58°C, respectively. Moreover, on extrapolating for 
AiV in cell culture media in 2-ml glass vial at 56°C, a D-value of 4.17 min is calculated, 
which accounts for a 4-D value of 16.68 min. Extrapolating a come-up time of approx. 
3.4 min from come up time versus temperature graph, it is seen that 4 log reduction in 
AiV titer was observed in 20.08 min, which is similar to previously reported near 
complete (4 log PFU/ml) reduction of AiV titers at 56°C in 1.8 ml microcentrifuge tube 
in a circulating water bath (10). This is also comparable to the previously reported D-
value of 4.03 min obtained on thermal treatment of TV in cell culture media in 
microcentrifuge tube at 56°C (2). 
Table 3.1 shows the shape and scale parameters for Weibull model for the 
different temperatures used to calculate Td = 1 value that was used as an analogue to 
D-value from first order model. The results revealed that the value of scale parameter, 
α ranged from 10.22 to 0.14 min when temperature increases from 50 to 58°C which 
is indicative of a shift in the graph of log (N/No) versus time towards the left implying 
that as temperature increases and value of α decreases, there is a faster reduction in 
the number of survivors over a shorter duration of time. Furthermore, it can also be 
seen that the values obtained for β show a tailing behavior (concave upward) at 50, 
54 and 58°C with β as 0.69, 0.34 and 0.45, respectively. This suggests that at lower 
temperature of 50°C, only the sensitive members of the population are destroyed but 
the remaining cells are infectious, while as the temperature is increased, the cells 
become damaged and start losing the ability to infect. 
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As opposed to the shape parameter, the scale factor decreased almost linearly 
with temperature, which can be expressed as: 
α =  −1.26[T(°C)] +  71.92                                            R2 = 0.76 
On using an average value of shape parameter of β = 0.49, the dependence of 
Td=1 values on α can be expressed as: 
Td=1 =  5.45α 
Td=1 values were 34.53 ± 0.03, 2.59 ± 0.05 and 0.91 ± 0.06 min for 50, 54 and 
58°C, respectively. The difference in D-values using the linear model and Td=1 values 
using the Weibull model can be ascribed to the pronounced curvature seen for number 
of survivors with respect to time owing to the low value of β of 0.3 at 50°C. This further 
indicates that there is a greater frequency of inactivation of the number of virus 
particles at shorter time points than that at higher time points (Table 3.2). For 
comparison, AiV with Td=1value of 34.53 min in 2-ml glass vials at 50°C was more heat 
resistant than MNV-1 or FCV-F9 with Td=1values of 26.78 and 13.27 min, respectively, 
but less heat resistant than HAV (Td=1of 39.91 min) under the same conditions (7). 
The first order model shows over processing for one log reduction as compared 
to the Weibull model. For industrial purposes, six log (6-D values) reduction is often 
used, which can be calculated by multiplying the D-value by a factor of six for first 
order model and substituting Td=6 for Weibull model (8). The results show that for the 
studied temperatures (50-58°C), the first order model shows under processing for the 
targeted six log reduction as compared to Weibull model (Table 3.3). Similar 
observation has been reported for FCV-F9, MNV-1 and HAV with 6-D values of 38.22, 
22.44 and 50.4 min and Td=6 values of 43.73, 29.66 and 58.57 min, respectively at 
56°C, showing under processing in case of first order model as compared Weibull 
model (5). The high regression coefficient suggests that the Weibull model is better 
representation of inactivation kinetics of AiV in cell culture media in 2-ml glass vials 
compared to first order model.  
Based on these results, AiV is shown to have higher resistance to heat than 
cultivable HNoV surrogates (MNV-1 and FCV-F9) when tested in cell-culture within 2-
ml glass vials at 50, 54 and 58oC. This data will be useful to the food industry in 
selecting optimum process conditions to obtain the desired level of inactivation, to 
prevent foodborne illnesses and outbreaks. Further studies are needed to determine 
the thermal inactivation behavior of AiV in food matrices such as shellfish. 
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7 APPENDIX 
Figures 
 
 
 
Figure 3.1. Comparison of thermal inactivation curves of Aichi virus (AiV) in cell 
culture media in 2 ml glass vials for (A) first order model (R2 = 0.98) and (B) 
Weibull model (R2 = 0.94). The data points represent Log10 D (A) or Td=1(B) (min) 
values for three replicates at 50, 54 and 58°C used for computing Z-values.  
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Tables 
 
Table 3.1. Coefficients of the first-order and Weibull models for the survival 
curves of Aichi virus (AiV) during thermal inactivation in cell culture media using 
2-ml glass vials.  
 Weibull distribution  First order kinetics 
T (°C) α(min) Td=1(min) β R2  D (min) R2 Z (°C) 
50 10.27 34.53±0.03 0.69 0.99  47.62±1.12 0.94 
5.92 54 0.22 2.59±0.05 0.34 0.96  7.14±1.13 0.70 
58 0.14 0.91±0.06 0.45 0.961  2.12±0.04 0.70 
 
*Thermal death time (Td=1, D- values ± SE), shape and scale factors (β and α, 
respectively) and coefficient of determination (R2). The data is the average of three 
replicates assayed in duplicate for each temperature. 
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Table 3.2. Effect of thermal treatment on Aichi virus in cell culture media using 
2-ml glass vials 
Temp (°C) Treatment 
Recovered titer log 
(PFU/ml) 
50 Control 7.30 ± 0.02 
 0 min 7.17 ± 0.03 
 0.5 min 7.03 ± 0.03 
 1 min 6.97 ± 0.02 
 2 min 6.93 ± 0.05 
 3 min 6.88 ± 0.03 
 5 min 6.85 ± 0.04 
 10 min 6.80 ± 0.03 
54 Control 7.41 ± 0.06 
 0 min 5.33 ± 0.25 
 0.5 min 4.89 ± 0.41 
 1 min 4.58 ± 0.23 
 2 min 4.31 ± 0.15 
 3 min 4.16 ± 0.05 
 5 min 3.93 ± 0.16 
 10 min 3.59 ± 0.07 
58 Control 7.44 ± 0.33 
 0 min 3.24 ± 0.10 
 0.25 min 2.67 ± 0.13 
 0.5 min 2.52 ± 0.07 
 0.75 min 2.30 ± 0.16 
 1 min 2.23 ± 0.20 
 1.25 min 2.14 ± 0.27 
 1.5 min 1.82 ± 0.13 
 2 min 1.74 ± 0.07 
 3 min 1.57 ± 0.10 
 
Each treatment was replicated thrice and assayed in duplicate for evaluation of 
inactivation of viruses (limit of detection was 1 log PFU/ml) 
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Table 3.3. Calculated process time (min) to achieve 6-log reduction of Aichi virus 
(AiV) during thermal inactivation in cell culture media in 2-ml glass vials by the 
first-order and Weibull models. 
 
Model 
Temperature (°C) 
50 54 58 
Time (min) 
First order (6D) 285.72 42.84 12.72 
Weibull (Td=6) 466.59 396.63 51.79 
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CONCLUSION 
Foodborne enteric viruses have been known to cause several outbreaks and 
illnesses. The current absence of available vaccines necessitates the development of 
alternative control strategies to control their spread. Thermal inactivation is one of the 
most widely used methods traditionally and in industry. 
This study determined the thermal inactivation kinetics of Tulane virus (TV) (a 
cultivable human norovirus surrogate) and Aichi virus (AiV). Based on the regression 
coefficients, the Weibull model showed a better fit for thermal inactivation kinetics of 
TV in cell culture media in 2-ml glass vials as well as for inoculated spinach in vacuum 
bags and for AiV in cell culture media in 2-ml glass vials. The study also showed that 
as the targeted temperature increased, the value for the scale parameter for the 
Weibull model decreased, showing that there were more number of viruses inactivated 
during a shorter frequency of time. 
 At 56°C in cell culture media in 2-ml glass vial, the D-value of TV was 2.91 min 
while murine norovirus (MNV-1) had D-value of 3.74 min (19). Similarly, at 50°C, D-
value of TV was 7.94 min in spinach in vacuum bags while MNV-1 had D-value of 
14.57 min in spinach in 2-ml glass vials (17). Furthermore, hepatitis A virus (HAV) had 
D-values of 8.4 min in cell culture media in 2-ml glass vial and 8.43 min in spinach in 
vacuum bags (24)(Bozkurt et al, 2015), while the D-value obtained for AiV was 47.62 
min at 50°C in cell culture media in 2-ml glass vials. 
Based on these results, AiV is shown to have greater resistance to heat in 
comparison to MNV-1, feline calicivirus (FCV-F9) and TV in cell culture media in 2-ml 
glass vials with D-values of 47.62 min at 50°C for AiV in 2-ml glass vials, as compared 
to TV of 7.94 min, MNV-1 of 36.28 min and FCV-F9 of 19.95 min. 
The overall results from this study show that TV did not appear to be a suitable 
HNoV surrogate when compared to murine norovirus (MNV-1) with regards to heat-
inactivation kinetics, as MNV-1 had higher heat resistance than TV in both cell-culture 
media and spinach. From the current results, it appears that for heat-inactivation, the 
lab-adapted HAV and even MNV-1 are more heat resistant than TV.  
Based on these results and with the knowledge that an ideal cultivable 
surrogate should have a similar structure and size to the target virus, be slightly more 
resistant to treatments, non-pathogenic, and easy to use in laboratory and industrial 
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settings, further studies are needed to determine a suitable HNoV surrogate for use in 
heat inactivation studies.  
These results will be useful to the food industry in selecting optimum process 
conditions to obtain the desired level of inactivation, to prevent foodborne viral 
illnesses and outbreaks. Further studies are needed to determine thermal inactivation 
behavior of AiV in food matrices such as shellfish. However, sensory and nutritional 
attributes need to be studied for industrial application using these thermal processing 
conditions in industry. 
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